I'm monitoring UnitedHealth Group (NYSE: UNH) for risk-profile changes. Using its risk factors, what are some of UNH's key disclosed risks, are those risks present in BOTH its latest annual report (the FY2025 Form 10-K) and the prior year's (FY2024) — so I can compare year over year — and has UNH flagged any NEW risk factors in the latest filing versus the prior one?
A real, unedited run·UNH·Sonnet 4.6·10 tool calls·3m 16s·$0.723
Replaying the run · 32 steps · 196s compressed
▸ THINKING
01 Thinking
02 Narration
03 Tool call · WaitForMcpServers
04 Result · WaitForMcpServers ✓ ok · 11 ch
05 Tool call · browse_company
06 Result · browse_company ✓ ok · 383 ch
07 Thinking
08 Narration
09 Tool call · list_filings
10 Tool call · get_filing_index
11 Result · list_filings ✓ ok · 12,063 ch
12 Result · get_filing_index ✓ ok · 26,596 ch
13 Thinking
14 Narration
15 Tool call · get_filing_section
16 Tool call · get_filing_section
17 Result · get_filing_section ✓ ok · 32,862 ch
18 Result · get_filing_section ✓ ok · 32,227 ch
19 Thinking
20 Narration
21 Tool call · get_filing_section
22 Tool call · get_filing_section
23 Result · get_filing_section ✓ ok · 29,978 ch
24 Result · get_filing_section ✓ ok · 31,886 ch
25 Thinking
26 Narration
27 Tool call · get_filing_section
28 Tool call · get_filing_section
29 Result · get_filing_section ✓ ok · 18,861 ch
30 Result · get_filing_section ✓ ok · 19,476 ch
31 Thinking
32 Final emit
TL;DR
Monitoring risk isn't reading one filing — it's diffing this year's risk factors against last year's to see what changed.
Risk surveillance is a year-over-year diff: which risks persist across both 10-Ks, and what's NEW this year. MetricDuck read the risk factors from both the FY2025 and FY2024 10-Ks — the Change Healthcare cyberattack and the web of government investigations (DOJ, SEC, IRS, DOL) appear in both — and flagged a new FY2025 risk factor around UNH's increasing use of artificial intelligence.
Sources (15) — every cited figure below traces to one of these
Every step the agent took — reasoning, tool calls, raw results. Click any cited figure to open it in the source filing.
01Thinking
The user wants to analyze UnitedHealth Group's (UNH) risk factors from their SEC filings. Specifically, they want:
1. Key disclosed risks from UNH's latest annual report (FY2025 Form 10-K)
2. Whether those risks are also present in the prior year's filing (FY2024 Form 10-K)
3. Any NEW risk factors in the latest filing versus the prior one
Let me use the MetricDuck MCP tools to retrieve this information. First, let me wait for the MCP servers to connect, then query for the risk factors.
02Narration
I'll start by waiting for the MetricDuck MCP tools, then query UNH's risk factors from both the FY2025 and FY2024 10-K filings.
03Tool call·WaitForMcpServers
{}
04Result·WaitForMcpServers✓ ok · 11 ch
ready: true
05Tool call·browse_company
{
"query": "UNH"
}
06Result·browse_company✓ ok · 383 ch
Found 3 matching companies. Retry browse_company with the exact ticker (or `cik` for delisted):
1. **UNH** - UNITEDHEALTH GROUP INC
_formerly: UNITED HEALTHCARE CORP_
CIK: 0000731766
2. **YHGJ** - YUNHONG GREEN CTI LTD.
_formerly: Yunhong CTI Ltd.; CTI INDUSTRIES CORP_
CIK: 0001042187
3. **HYSR** - SUNHYDROGEN, INC.
_formerly: Hypersolar, Inc._
CIK: 0001481028
07Thinking
Now let me look up the FY2025 and FY2024 10-K filings for UNH. I need to:
1. Get the filing index for the FY2025 10-K (risk trajectory lens)
2. Get the filing index for the FY2024 10-K (risk trajectory lens)
3. Then read the actual risk factors sections from both
Let me first list the filings to find the right accession numbers, then check dates to make sure they're on or before 2026-03-02.
08Narration
Now let me pull the list of 10-K filings and the risk-trajectory signal index for both FY2025 and FY2024 in parallel.
›list_filings("UNH", form_type="8-K")—Browse prior earnings 8-Ks (each typically has a transcript)
›compare_companies("UNH")—Peer context
13Thinking
The filing index returned data mostly about earnings calls and not much about the risk trajectory in the 10-K. The FY2025 10-K was filed on 2026-03-02 which is exactly our vantage date, so it is valid. The FY2024 10-K was filed on 2025-02-27 which is before 2026-03-02, also valid.
Now I need to read the actual risk factors sections from both the FY2025 10-K (accession: 0000731766-26-000062) and the FY2024 10-K (accession: 0000731766-25-000063).
I'll pull the risk factors section directly from both filings since the structured facts weren't populated in the earlier search.
14Narration
Both 10-K filings check out (FY2025 filed 2026-03-02 ✓, FY2024 filed 2025-02-27 ✓). Now let me pull the risk factors text from both in parallel.
15Tool call·get_filing_section
{
"ticker": "UNH",
"section_id": "risk_factors",
"accession_number": "0000731766-26-000062",
"max_chars": 30000
}
16Tool call·get_filing_section
{
"ticker": "UNH",
"section_id": "risk_factors",
"accession_number": "0000731766-25-000063",
"max_chars": 30000
}
17Result·get_filing_section✓ ok · 32,862 ch
# UNH — risk_factors
10-K FY FY2025 (filed 2026-03-02)
~11,225 words | Chunks 1-10 of 25
[UNH | 10-K FY 2025 | Risk Factors | Chunk 1/25]
ITEM 1A. RISK FACTORS
CAUTIONARY STATEMENTS
The statements, estimates, projections or outlook contained in this Annual Report on Form 10-K include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). When used in this Annual Report on Form 10-K and in future filings by us with the SEC, in our news releases, presentations to securities analysts or investors, and in oral statements made by or with the approval of one of our executive officers, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “forecast,” “outlook,” “plan,” “project,” “should” or similar words or phrases are intended to identify such forward-looking statements. These statements are intended to take advantage of the “safe harbor” provisions of the PSLRA. These forward-looking statements involve risks and uncertainties which may cause our actual results to differ materially from the expectations expressed or implied in the forward-looking statements. Any forward-looking statement in this report speaks only as of the date of this report and, except as required by law, we undertake no obligation to update any forward-looking statement to reflect events or circumstances, including unanticipated events, after the date of this report.
The following discussion contains cautionary statements regarding our business, which investors and others should consider. We do not undertake to address in future filings with the SEC or other communications regarding our business or results of operations how any of these factors may have caused our results to differ from discussions or information contained in our previous filings or communications. In addition, any of the matters discussed below may have affected past, as well as current, forward-looking statements about future results.
Any or all forward-looking statements in this Annual Report on Form 10-K and in any other SEC filings or public statements we make may turn out to be wrong. Our forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions which are difficult to predict or quantify.
The risks and uncertainties discussed below are not the only risks we may face. There may be risks and uncertainties not currently known to us or that we may deem to be immaterial that could materially and adversely affect our business, results of operations, financial position, cash flows and prospects.
Risks Related to Our Business and Our Industry
If we fail to estimate, price for and manage our medical costs or design benefits in an effective manner, the profitability of our risk-based products and services could decline and could materially and adversely affect our results of operations, financial position and cash flows.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 2/25]
Through our risk-based benefit products, we assume the risk of both medical and administrative costs for our customers in return for monthly premiums. The profitability of our products depends in large part on our ability to predict and effectively price for and manage medical costs. Our Optum Health business also enters into fully accountable value-based arrangements with payers. Premium revenues from risk-based products constitute nearly 80% of our total consolidated revenues. Estimates of benefit expense payments involve extensive judgement and are subject to considerable inherent variability. Relatively small differences between predicted and actual medical costs, or utilization rates as a percentage of revenues, have resulted and in the future may result in significant changes in our financial results. If we fail to predict accurately, or effectively price for or manage, the costs of providing care under risk-based arrangements, our results of operations could be materially and adversely affected.
We manage medical costs through underwriting criteria, product design, negotiation of competitive provider contracts and care management programs. Total medical costs are affected by the number of individual services rendered, the cost of each service and the type of service rendered. Although we base the premiums we charge on our estimates of future medical costs over the fixed contract period, many factors may cause, and have previously caused, actual costs to exceed those estimated and reflected in premiums or bids. These factors may include medical cost inflation, increased use of services, increased provider billing intensity, business mix, unexpected differences among new customer populations, increased cost of individual services, costs to deliver care, large-scale medical emergencies, the potential effects of climate change, pandemics, the introduction of new or costly drugs or increases in drug prices, treatments and technology, new treatment guidelines, newly mandated benefits or other regulatory changes and insured population characteristics. Cost increases in excess of our forecasts typically cannot be recovered in the fixed premium period through higher premiums. For Optum Health’s fully accountable value-based care, any inability to provide higher-quality outcomes and better experiences at lower costs or to integrate our care delivery models could impact our results of operations, financial positions and cash flows.
In addition, the financial results we report for any particular period include estimates of costs incurred for which claims are still outstanding. These estimates involve an extensive degree of judgment. If these estimates prove inaccurate, our results of operations could be materially and adversely affected.
If we fail to maintain properly the integrity or availability of our data or successfully consolidate, integrate, upgrade or expand our existing information systems, or if our technology products do not operate as intended, our business could be materially and adversely affected.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 3/25]
Our business depends on the integrity and timeliness of the data we use to serve our members, customers and health care professionals and to operate our business. If the data we rely upon to run our businesses is found to be inaccurate, incomplete, outdated or unreliable or if we fail to effectively maintain or protect the integrity of our data and information systems, including systems powered by or incorporating artificial intelligence (AI), we could experience failures in our health, wellness and information technology products; lose existing customers; have difficulty attracting new customers; experience problems in determining medical cost estimates and establishing appropriate pricing; have difficulty preventing, detecting and controlling fraud; have disputes with customers, physicians and other health care professionals; become subject to regulatory sanctions, penalties, investigations or audits; incur increases in operating expenses; or suffer other adverse consequences.
The volume of health care data generated, and the uses of data, including electronic health records, are rapidly expanding. We depend on the integrity of the data in our information systems to implement new and innovative services, automate and deploy new technologies to simplify administrative processes and clinical decision making, price our products and services adequately, provide effective service to our customers and consumers in an efficient and uninterrupted fashion, provide timely payments to care providers, and accurately report our results of operations. In addition, increasing connectivity among technologies and recent trends toward greater consumer engagement in health care require new and enhanced technologies, including more sophisticated applications for mobile devices and new tools and products that leverage AI to improve the customer experience. We anticipate that fast-evolving AI technologies, including generative AI, will play an increasingly important role in our information systems and customer-facing technology products. Our ability to protect and enhance existing systems and develop new systems to keep pace with changes in information processing technology (including AI), regulatory standards and changing customer preferences will require our ongoing commitment of significant development and operational resources. If these commitments fail to provide the anticipated benefits, if we are unable to successfully anticipate future technology developments, or if the cost to keep pace with the technological changes exceeds our estimates, we could be exposed to reputational harm and experience adverse effects on our business.
We may not successfully implement our initiatives to consolidate the number of information systems we operate, upgrade and expand our systems’ capabilities, integrate and enhance our systems and develop new systems to keep pace with recent
[UNH | 10-K FY 2025 | Risk Factors | Chunk 4/25]
regulations and changes in information processing technology. Failure to protect, consolidate and integrate our systems successfully could result in higher than expected costs.
Some of our businesses sell and install software products which may contain unexpected design defects or may encounter unexpected complications during installation or when used with other technologies utilized by the customer. A failure of our technology products to operate as intended and in a fully-integrated fashion with other products could materially and adversely affect our results of operations, financial position and cash flows.
Uncertain and rapidly evolving U.S. federal and state, non-U.S. and international laws and regulations related to health data and health information technologies, including those powered by or incorporating AI, may alter the competitive landscape or impose new compliance requirements and could materially and adversely affect the configuration of our information systems and platforms, and our ability to compete in our markets.
If we or third parties we rely on sustain cyberattacks or other privacy or data security incidents resulting in disruption to our operations or the misappropriation or disclosure of protected personal information or proprietary or confidential information, we could suffer a loss of revenue and increased costs, negative operational effects, exposure to significant liability, reputational harm and other serious negative consequences.
We routinely process, store and transmit large amounts of data in our operations, including protected personal information subject to privacy, security or data breach notification laws, as well as proprietary or confidential information relating to our business or third parties. Some of the data we process, store and transmit may be outside of the United States due to our information technology systems and international business operations. We are regularly the target of attempted cyberattacks and other security threats and have previously been, and may in the future be, subject to compromises of the information technology systems we use, information we hold, or information held on our behalf by third parties. For example, we previously reported that our Change Healthcare business, which we had recently acquired, was subject to a cyberattack in 2024, in which the data involved contained protected health information or personally identifiable information.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 5/25]
While we have programs in place to detect, contain and respond to data security incidents and provide employees with awareness training regarding phishing, malware and other cyber threats as a protection against cybersecurity risks and incidents, we expect that we will continue to experience incidents, some of which may negatively affect our business. Further, because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and are increasing in sophistication, in part due to use of evolving AI technologies (including generative AI), and because our businesses are changing as well, we may be unable to anticipate these techniques and threats, timely detect data security incidents or implement adequate preventive measures. Threat actors and hackers have previously been, and may in the future be, able to negatively affect our operations by penetrating our security controls and causing system and operational disruptions or shutdowns. They may access, misappropriate or otherwise compromise protected personal information or our proprietary or confidential information or that of third parties, and may develop and deploy malicious code (including viruses, ransomware and malware, among others) that can attack our systems, exploit security vulnerabilities, and disrupt or shut down our systems and operations. In addition, hardware, software, or applications we develop or procure from third parties may contain defects or other problems which could unexpectedly compromise our information technology ecosystem. Our systems may also be vulnerable to financial fraud schemes, misplaced or lost data, human error, insider threat, malicious social engineering, or other events which could negatively affect the data or financial accounts, proprietary or confidential information relating to our business or third parties, or our operations. There have previously been and may be in the future heightened vulnerabilities due to recently-acquired or non-integrated businesses. We rely in some circumstances on third-party vendors to process, store and transmit large amounts of data for our business. The operations of these vendors are subject to similar risks, but are outside our direct oversight and control.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 6/25]
The costs to eliminate or address these threats and vulnerabilities before or after a cybersecurity incident could be material. We have business continuity and resiliency plans which we maintain, update and test regularly in an effort to contain and remediate potential disruptions from cybersecurity events. If our prevention and remediation efforts are not successful, we may experience operational interruptions, delays, or cessation of service and loss of existing or potential customers. In addition, compromises of our security measures or the unauthorized dissemination of sensitive personal information, proprietary information or confidential information about us, our customers or other third parties, previously and in the future, could expose us or them to the risk of financial or medical identity theft, negative operational impacts, and loss or misuse of this information, result in litigation and liability, including regulatory penalties, for us, damage our brand and reputation, or otherwise harm our business.
If we fail to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers, our business could be materially and adversely affected.
We depend substantially on our continued ability to contract with health care payers (as a service provider to those payers), as well as physicians, hospitals, pharmaceutical benefit service providers, pharmaceutical manufacturers and other care and service providers at competitive prices. If we fail to develop and maintain satisfactory relationships with health care providers, whether in-network or out-of-network, our failure to do so could materially and adversely affect our business, results of operations,
financial position and cash flows. In addition, some of our activities related to network design, provider participation in networks and provider payments could result in disputes, which may be costly and attract negative publicity.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 7/25]
In any particular market, physicians and health care providers could refuse to contract with us, demand higher payments, or take other actions which could result in higher medical costs, less desirable products for customers or difficulty meeting regulatory or accreditation requirements. In some markets, certain health care providers, particularly hospitals, physician and hospital organizations or multi-specialty physician groups, may have significant market positions which could diminish our bargaining power. In addition, Accountable Care Organizations (ACOs), physician group management services organizations (which aggregate physician practices for administrative efficiency), and other organizational structures adopted by physicians, hospitals and other care providers may change the way in which these providers do business with us and may change the competitive landscape. Such organizations or groups of physicians may compete directly with us, which could adversely affect our business, and our results of operations, financial position and cash flows by impacting our relationships with these providers or affecting the way we price our products and estimate our costs, which might require us to incur costs to change our operations in an effort to mitigate these impacts. In addition, if these providers refuse to contract with us, use their market position to negotiate favorable contracts or place us at a competitive disadvantage, our ability to market products or to be profitable in those areas could be materially and adversely affected.
Our health care benefits businesses have risk-based arrangements with some physicians, hospitals and other health care providers. These arrangements limit our exposure to the risk of increasing medical costs, but expose us to risk related to the adequacy of the financial and medical care resources of the health care providers. To the extent a risk-based health care provider organization faces financial difficulties or otherwise is unable to perform its obligations under the arrangement, we may be held responsible for unpaid health care claims which should have been the responsibility of the health care provider and for which we have already paid the provider. Further, payment or other disputes between a primary care provider and specialists with whom the primary care provider contracts could result in a disruption in the provision of services to our members or a reduction in the services available to our members. Health care providers with which we contract may not properly manage the costs of services, maintain financial solvency or avoid disputes with other providers. They may also fail to provide us with the information we need to effectively conduct our businesses, such as information enabling us to estimate costs of care. Any of these events could have a material adverse effect on the provision of services to our members and our operations.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 8/25]
Some providers that render services to our members do not have contracts with us. In some instances, those providers have disputed and may in the future dispute the payment for these services and may institute litigation or arbitration relying on state and federal laws that define the compensation that must be paid to out-of-network providers in some circumstances.
The success of some of our businesses depends on maintaining satisfactory relationships with employed, affiliated, and independently contracted physicians and joint venture partners. The physicians who practice medicine or contract with our affiliated physician organizations could terminate their provider contracts or otherwise become unable or unwilling to continue practicing medicine or contracting with us. We face and will likely continue to face heightened competition to acquire or manage physician practices or to employ or contract with individual physicians. Our revenues could be materially and adversely affected if we are unable to maintain or expand satisfactory relationships with physicians, to acquire, recruit or, in some instances, employ physicians, or to retain enrollees following physician departures. In addition, our affiliated physician organizations contract with competitors of UnitedHealthcare. Our businesses could suffer if our affiliated physician organizations fail to maintain relationships with or fail to adequately price their contracts with these third-party payer competitors.
Further, physicians, hospitals, pharmaceutical benefit service providers, pharmaceutical manufacturers and certain health care providers are customers of our Optum businesses. Physicians also provide medical services at facilities owned by our Optum businesses. Given the importance of health care providers and other constituents to our businesses, failure to maintain satisfactory relationships with them could materially and adversely affect our results of operations, financial position and cash flows.
If we fail to compete effectively to maintain or increase our market share, including by maintaining or increasing enrollments in businesses providing health benefits, our results of operations, financial position and cash flows
could be materially and adversely affected.
Our businesses face significant competition in all of the markets in which we operate. In many geographies or product segments, our competitors have and may continue to have competitive advantages. Our competitive position may also be adversely affected by significant merger and acquisition activity in the industries in which we operate, among both our competitors and suppliers. Consolidation among competitors may make it more difficult for us to retain or increase our customer base, maintain or improve the terms on which we do business with our suppliers, or maintain or increase our profitability.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 9/25]
In addition, our success in the health care marketplace and future growth depends on our ability to develop and deliver innovative and potentially disruptive products and services to satisfy evolving market demands. If we do not continue to
innovate and provide products and services which are useful and relevant to health care payers, consumers and our customers, we may not remain competitive and risk losing market share to existing competitors and disruptive new market entrants. We may face risks from new technologies and market entrants that could affect our existing relationship with health plan enrollees in the affected markets. We could sustain competitive disadvantages and loss of market share if we fail to continue developing innovative care models, including by accelerating the transition of care to value-based models that achieve higher quality outcomes and better experiences at lower costs and expand access to virtual and in-home care. If health care payers or providers are unwilling or unable to enter into value-based agreements with us, we may be unable to successfully establish or maintain the contractual or employment relationships necessary to achieve the quality and cost objectives we have for value-based contracting. Additionally, our competitive position could be adversely affected by any failure to develop and apply innovative technologies and other effective data and analytics capabilities or to provide services to our clients focused on these technologies and capabilities.
Our business, results of operations, financial position and cash flows also could be materially and adversely affected if we do not compete effectively in our markets, if our reputation suffers harm, if we set rates too high or too low in highly competitive markets, if we do not design and price our products properly and competitively, if we are unable to innovate and deliver products and services demonstrating value to our customers, if we do not provide a satisfactory level of services, if membership or demand for other services does not increase as we expect or declines, or if we lose accounts with more profitable products while retaining or increasing membership in accounts with less profitable products.
We are routinely subject to private party and governmental legal actions and investigations, which could damage our reputation and, if resolved unfavorably, could result in substantial penalties or monetary damages and materially and adversely affect our results of operations, financial position and cash flows.
We are routinely made party to a variety of private party and governmental legal actions and investigations related to, among other matters, the design, management and delivery of our product and service offerings. Any failure by us to adhere to the laws and regulations applicable to our businesses could subject us to civil and criminal penalties.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 10/25]
Legal actions to which we are a party have included and in the future could include matters related to health care benefits coverage and payment of claims (including disputes with enrollees, customers and contracted and non-contracted physicians, hospitals and other health care professionals), tort claims (including claims related to the delivery of health care services, such as medical malpractice by personnel at our affiliates’ facilities, or by health care practitioners who are employed by us, have contractual relationships with us, or serve as providers to our managed care networks, including as a result of a failure to adhere to applicable clinical, quality and/or patient safety standards), antitrust claims (including as a result of changes in the enforcement of antitrust laws), whistleblower claims (including claims under the False Claims Act or similar statutes), matters related to our use of or alleged failure to adequately safeguard personal information or other proprietary data, claims related to alleged failure of our technology products to operate properly or fairly, contract and labor disputes, tax claims and claims related to disclosure of certain business practices. In addition, some of our pharmacy services operations are subject to clinical quality, patient safety and other risks inherent in the dispensing, packaging and distribution of drugs, including claims related to purported dispensing and other operational errors. We also have been and in the future may be a party to class action lawsuits, including those brought by health care professional groups, consumers and investors. We operate in jurisdictions where contractual rights, tax positions and applicable regulations may be subject to varying degrees of interpretation or uncertainty, and therefore subject to dispute by customers, government authorities or others.
We are largely self-insured with regard to legal actions, including claims of medical malpractice against our affiliated physicians and us. Although we record liabilities for our estimates of the probable costs resulting from self-insured matters, it is possible the level of actual losses will significantly exceed the liabilities recorded. Additionally, physicians and other healthcare providers have become subject to an increasing number of legal actions alleging medical malpractice and general professional liabilities.
Even in states that have imposed caps on damages for such actions, litigants are seeking recoveries under theories of liability that might not be subject to the caps on damages. These actions involve significant defense costs and could result in substantial monetary damages or damage to our reputation.
---
SEC Filing: sec.gov/…↗
MetricDuck Viewer: viewer.metricduck.com/…#section-risk_factors↗
Accession: 0000731766-26-000062
Citation: mdck://UNH/0000731766-26-000062/risk_factors#c0
Chunk handles (cite the chunk a quoted figure came from):
c0 → mdck://UNH/0000731766-26-000062/risk_factors#c0
c1 → mdck://UNH/0000731766-26-000062/risk_factors#c1
c2 → mdck://UNH/0000731766-26-000062/risk_factors#c2
c3 → mdck://UNH/0000731766-26-000062/risk_factors#c3
c4 → mdck://UNH/0000731766-26-000062/risk_factors#c4
c5 → mdck://UNH/0000731766-26-000062/risk_factors#c5
c6 → mdck://UNH/0000731766-26-000062/risk_factors#c6
c7 → mdck://UNH/0000731766-26-000062/risk_factors#c7
c8 → mdck://UNH/0000731766-26-000062/risk_factors#c8
c9 → mdck://UNH/0000731766-26-000062/risk_factors#c9
›get_filing_section(cik="0000731766", section_id="risk_factors", offset=10)—Page 2 of 3
**Structured tables in this filing** — disaggregated figures behind this section's prose. Query these (not the prose) for the numbers:
- `table_debt_maturities` — Debt Maturities Schedule
- `table_deferred_taxes` — Deferred Tax Assets and Liabilities
- `table_fair_value` — Fair Value Measurements Schedule
- `table_goodwill` — Goodwill Schedule
- `table_ppe` — Property, Plant and Equipment Schedule
- `table_segment_reporting` — Segment Reporting Schedule
Or read the as-filed percentages directly: `get_xbrl_facts(cik="0000731766", search="concentration")` (revenue share by customer / channel / geography / product).
**Other sections in this filing:**
- `accountant_changes` (Changes in and Disagreements with Accountants) — ~14 words
- `business_description` (Business Description) — ~6,691 words
- `controls_procedures` (Controls and Procedures) — ~1,191 words
- `cybersecurity` (Cybersecurity) — ~805 words
- `footnote_accounting_policies` (Summary of Significant Accounting Policies) — ~5,387 words
- `footnote_business_combinations` (Business Combinations) — ~579 words
- `footnote_cash_investments` (Cash and Investments) — ~3,106 words
- `footnote_commitments` (Commitments and Contingencies) — ~1,114 words
- `footnote_credit_loss` (Allowance for Credit Losses) — ~104 words
- `footnote_debt` (Debt and Credit Facilities) — ~2,437 words
- `footnote_derivatives` (Derivative Financial Instruments) — ~525 words
- `footnote_eps` (Earnings Per Share) — ~345 words
- `footnote_equity` (Stockholders' Equity) — ~1,078 words
- `footnote_fair_value` (Fair Value Measurements) — ~2,855 words
- `footnote_goodwill` (Goodwill and Intangible Assets) — ~1,585 words
- `footnote_income_tax` (Income Taxes) — ~3,632 words
- `footnote_leases` (Leases) — ~111 words
- `footnote_pension` (Pension and Post-Retirement Benefits) — ~126 words
- `footnote_ppe` (Property, Plant and Equipment) — ~4,021 words
- `footnote_revenue` (Revenue Recognition) — ~1,134 words
- `footnote_segment` (Segment Information) — ~4,799 words
- `footnote_stock_comp` (Stock-Based Compensation) — ~2,012 words
- `footnotes_introduction` (Notes to Financial Statements - Introduction) — ~83 words
- `legal_proceedings` (Legal Proceedings) — ~54 words
- `market_equity` (Market for Common Equity) — ~273 words
- `market_risk` (Market Risk Disclosures) — ~587 words
- `mda_critical_accounting` (Critical Accounting Policies)
- `mda_full` (Management's Discussion and Analysis) — ~26,327 words
- `mda_liquidity` (Liquidity and Capital Resources)
- `mda_outlook`
- `mda_results_operations` (Results of Operations)
- `mine_safety` (Mine Safety Disclosures) — ~10 words
- `other_information_10k` (Other Information (10-K)) — ~66 words
- `policy_cash_equivalents` (Cash and Cash Equivalents Policy) — ~45 words
- `policy_consolidation` (Consolidation Policy) — ~43 words
- `policy_fair_value` (Fair Value Measurement Policy) — ~1,003 words
- `policy_leases` (Leases Policy) — ~111 words
- `policy_ppe` (Property, Plant and Equipment Policy) — ~130 words
- `policy_receivables` (Receivables and Credit Loss Policy) — ~172 words
- `policy_revenue_recognition` (Revenue Recognition Policy) — ~1,134 words
- `properties` (Properties) — ~453 words
- `risk_factors_risks_related_to_our_business_and_our_industry`
- `risk_factors_risks_related_to_the_regulation_of_our_business`
- `signature_officers` (Signatures (Executive Officers)) — ~489 words
- `table_debt_maturities` (Debt Maturities Schedule) — ~64 words
- `table_deferred_taxes` (Deferred Tax Assets and Liabilities) — ~343 words
- `table_fair_value` (Fair Value Measurements Schedule) — ~678 words
- `table_goodwill` (Goodwill Schedule) — ~237 words
- `table_ppe` (Property, Plant and Equipment Schedule) — ~42 words
- `table_segment_reporting` (Segment Reporting Schedule) — ~2,300 words
- `unresolved_staff_comments` (Unresolved Staff Comments) — ~6 words
_Drill in via `get_filing_section(cik="0000731766", accession_number="0000731766-26-000062", section_id="...")`._
18Result·get_filing_section✓ ok · 32,227 ch
# UNH — risk_factors
10-K FY FY2024 (filed 2025-02-27)
~10,686 words | Chunks 1-10 of 26
[UNH | 10-K FY 2024 | Risk Factors | Chunk 1/26]
ITEM 1A. RISK FACTORS
CAUTIONARY STATEMENTS
The statements, estimates, projections or outlook contained in this Annual Report on Form 10-K include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). When used in this Annual Report on Form 10-K and in future filings by us with the SEC, in our news releases, presentations to securities analysts or investors, and in oral statements made by or with the approval of one of our executive officers, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “forecast,” “outlook,” “plan,” “project,” “should” or similar words or phrases are intended to identify such forward-looking statements. These statements are intended to take advantage of the “safe harbor” provisions of the PSLRA. These forward-looking statements involve risks and uncertainties which may cause our actual results to differ materially from the expectations expressed or implied in the forward-looking statements. Any forward-looking statement in this report speaks only as of the date of this report and, except as required by law, we undertake no obligation to update any forward-looking statement to reflect events or circumstances, including unanticipated events, after the date of this report.
The following discussion contains cautionary statements regarding our business, which investors and others should consider. We do not undertake to address in future filings with the SEC or other communications regarding our business or results of operations how any of these factors may have caused our results to differ from discussions or information contained in our previous filings or communications. In addition, any of the matters discussed below may have affected past, as well as current, forward-looking statements about future results. Any or all forward-looking statements in this Annual Report on Form 10-K and in any other SEC filings or public statements we make may turn out to be wrong. Our forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Many factors discussed below will be important in determining our future results. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions which are difficult to predict or quantify.
Risks Related to Our Business and Our Industry
If we fail to estimate, price for and manage our medical costs or design benefits in an effective manner, the profitability of our risk-based products and services could decline and could materially and adversely affect our results of operations, financial position and cash flows.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 2/26]
Through our risk-based benefit products, we assume the risk of both medical and administrative costs for our customers in return for monthly premiums. The profitability of our products depends in large part on our ability to predict and effectively price for and manage medical costs. Our Optum Health business also enters into fully accountable value-based arrangements with payers. Premium revenues from risk-based products constitute nearly 80% of our total consolidated revenues. Estimates of benefit expense payments involve extensive judgement and are subject to considerable inherent variability. Relatively small differences between predicted and actual medical costs, or utilization rates as a percentage of revenues, have resulted and in the future may result in significant changes in our financial results. If we fail to predict accurately, or effectively price for or manage, the costs of providing care under risk-based arrangements, our results of operations could be materially and adversely affected.
We manage medical costs through underwriting criteria, product design, negotiation of competitive provider contracts and care management programs. Total medical costs are affected by the number of individual services rendered, the cost of each service and the type of service rendered. Although we base the premiums we charge on our estimates of future medical costs over the fixed contract period, many factors may cause, and have previously caused, actual costs to exceed those estimated and reflected in premiums or bids. These factors may include medical cost inflation, increased use of services, business mix, unexpected differences among new customer populations, increased cost of individual services, costs to deliver care, large-scale medical emergencies, the potential effects of climate change, pandemics, the introduction of new or costly drugs or increases in drug prices, treatments and technology, new treatment guidelines, newly mandated benefits or other regulatory changes and insured population characteristics. Cost increases in excess of our forecasts typically cannot be recovered in the fixed premium period through higher premiums. For Optum Health’s fully accountable value-based care, any inability to provide higher-quality outcomes and better experiences at lower costs or to integrate our care delivery models could impact our results of operations, financial positions and cash flows.
In addition, the financial results we report for any particular period include estimates of costs incurred for which claims are still outstanding. These estimates involve an extensive degree of judgment. If these estimates prove inaccurate, our results of operations could be materially and adversely affected.
If we fail to maintain properly the integrity or availability of our data or successfully consolidate, integrate, upgrade or expand our existing information systems, or if our technology products do not operate as intended, our business could be materially and adversely affected.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 3/26]
Our business depends on the integrity and timeliness of the data we use to serve our members, customers and health care professionals and to operate our business. If the data we rely upon to run our businesses is found to be inaccurate or unreliable or if we fail to effectively maintain or protect the integrity of our data and information systems, including systems powered by or incorporating artificial intelligence and machine learning (AI/ML), we could experience failures in our health, wellness and information technology products; lose existing customers; have difficulty attracting new customers; experience problems in determining medical cost estimates and establishing appropriate pricing; have difficulty preventing, detecting and controlling fraud; have disputes with customers, physicians and other health care professionals; become subject to regulatory sanctions, penalties, investigations or audits; incur increases in operating expenses; or suffer other adverse consequences.
The volume of health care data generated, and the uses of data, including electronic health records, are rapidly expanding. We depend on the integrity of the data in our information systems to implement new and innovative services, automate and deploy new technologies to simplify administrative processes and clinical decision making, price our products and services adequately, provide effective service to our customers and consumers in an efficient and uninterrupted fashion, provide timely payments to care providers, and accurately report our results of operations. In addition, increasing connectivity among technologies and recent trends toward greater consumer engagement in health care require new and enhanced technologies, including more sophisticated applications for mobile devices and new tools and products that leverage AI/ML to improve the customer experience. We anticipate that fast-evolving AI/ML technologies, including generative AI, will play an increasingly important role in our information systems and customer-facing technology products. Our ability to protect and enhance existing systems and develop new systems to keep pace with changes in information processing technology (including AI/ML), regulatory standards and changing customer preferences will require an ongoing commitment of significant development and operational resources. If these commitments fail to provide the anticipated benefits, if we are unable to successfully anticipate future technology developments, or if the cost to keep pace with the technological changes exceeds our estimates, we could be exposed to reputational harm and experience adverse effects on our business.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 4/26]
We may not successfully implement our initiatives to consolidate the number of systems we operate, upgrade and expand our information systems’ capabilities, integrate and enhance our systems and develop new systems to keep pace with recent regulations and changes in information processing technology. Failure to protect, consolidate and integrate our systems successfully could result in higher than expected costs.
Some of our businesses sell and install software products which may contain unexpected design defects or may encounter unexpected complications during installation or when used with other technologies utilized by the customer. A failure of our technology products to operate as intended and in a seamless fashion with other products could materially and adversely affect our results of operations, financial position and cash flows.
Uncertain and rapidly evolving U.S. federal and state, non-U.S. and international laws and regulations related to health data and health information technologies, including those powered by or incorporating AI/ML, may alter the competitive landscape or impose new compliance requirements and could materially and adversely affect the configuration of our information systems and platforms, and our ability to compete in our markets.
If we or third parties we rely on sustain cyberattacks or other privacy or data security incidents resulting in disruption to our operations or the disclosure of protected personal information or proprietary or confidential information, we could suffer a loss of revenue and increased costs, negative operational effects, exposure to significant liability, reputational harm and other serious negative consequences.
We routinely process, store and transmit large amounts of data in our operations, including protected personal information subject to privacy, security or data breach notification laws, as well as proprietary or confidential information relating to our business or third parties. Some of the data we process, store and transmit may be outside of the United States due to our information technology systems and international business operations. We are regularly the target of attempted cyberattacks and other security threats and have previously been, and may in the future be, subject to compromises of the information technology systems we use, information we hold, or information held on our behalf by third parties. For example, we previously reported our Change Healthcare business, which we had recently acquired, was subject to a cyberattack in 2024, in which the data involved contained protected health information or personally identifiable information.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 5/26]
While we have programs in place to detect, contain and respond to data security incidents and provide employee awareness training regarding phishing, malware and other cyber threats to protect against cybersecurity risks and incidents, we expect that we will continue to experience these incidents, some of which may negatively affect our business. Further, because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and are increasing in sophistication, in part due to use of evolving AI/ML technologies (including generative AI), and because our businesses are changing as well, we may be unable to anticipate these techniques and threats, timely detect data security
incidents or implement adequate preventive measures. Threat actors and hackers have previously been, and may in the future be, able to negatively affect our operations by penetrating our security controls and causing system and operational disruptions or shutdowns, accessing, misappropriating or otherwise compromising protected personal information or proprietary or confidential information or that of third parties, and developing and deploying viruses, ransomware and other malware that can attack our systems, exploit any security vulnerabilities, and disrupt or shutdown our systems and operations. In addition, hardware, software, or applications we develop or procure from third parties may contain defects or other problems which could unexpectedly compromise our information security controls. Our systems may also be vulnerable to financial fraud schemes, misplaced or lost data, error, malicious social engineering, or other events which could negatively affect the data or financial accounts, proprietary or confidential information relating to our business or third parties, or our operations. There have previously been and may be in the future heightened vulnerabilities due to recently-acquired or non-integrated businesses. We rely in some circumstances on third-party vendors to process, store and transmit large amounts of data for our business. The operations of these vendors are subject to similar risks, but are outside our direct oversight and control.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 6/26]
The costs to eliminate or address the foregoing security threats and vulnerabilities before or after a cybersecurity incident could be material. We have business continuation and resiliency plans which we maintain, update and test regularly in an effort to contain and remediate potential disruptions or cybersecurity events. If our remediation efforts are not successful, we may experience operational interruptions, delays, or cessation of service and loss of existing or potential customers. In addition, compromises of our security measures or the unauthorized dissemination of sensitive personal information, proprietary information or confidential information about us, our customers or other third parties, previously and in the future, could expose us or them to the risk of financial or medical identity theft, negative operational impacts, and loss or misuse of this information, result in litigation and liability, including regulatory penalties, for us, damage our brand and reputation, or otherwise harm our business.
If we fail to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers, our business could be materially and adversely affected.
We depend substantially on our continued ability to contract with health care payers (as a service provider to those payers), as well as physicians, hospitals, pharmaceutical benefit service providers, pharmaceutical manufacturers and other care and service providers at competitive prices. If we fail to develop and maintain satisfactory relationships with health care providers, whether in-network or out-of-network, our failure to do so could materially and adversely affect our business, results of operations, financial position and cash flows. In addition, some of our activities related to network design, provider participation in networks and provider payments could result in disputes, which may be costly and attract negative publicity.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 7/26]
In any particular market, physicians and health care providers could refuse to contract with us, demand higher payments, or take other actions which could result in higher medical costs, less desirable products for customers or difficulty meeting regulatory or accreditation requirements. In some markets, certain health care providers, particularly hospitals, physician and hospital organizations or multi-specialty physician groups, may have significant market positions which could diminish our bargaining power. In addition, Accountable Care Organizations (ACOs); physician group management services organizations (which aggregate physician practices for administrative efficiency); and other organizational structures adopted by physicians, hospitals and other care providers may change the way in which these providers do business with us and may change the competitive landscape. Such organizations or groups of physicians may compete directly with us, which could adversely affect our business, and our results of operations, financial position and cash flows by impacting our relationships with these providers or affecting the way we price our products and estimate our costs, which might require us to incur costs to change our operations in an effort to mitigate these impacts. In addition, if these providers refuse to contract with us, use their market position to negotiate favorable contracts or place us at a competitive disadvantage, our ability to market products or to be profitable in those areas could be materially and adversely affected.
Our health care benefits businesses have risk-based arrangements with some physicians, hospitals and other health care providers. These arrangements limit our exposure to the risk of increasing medical costs, but expose us to risk related to the adequacy of the financial and medical care resources of the health care providers. To the extent a risk-based health care provider organization faces financial difficulties or otherwise is unable to perform its obligations under the arrangement, we may be held responsible for unpaid health care claims which should have been the responsibility of the health care provider and for which we have already paid the provider. Further, payment or other disputes between a primary care provider and specialists with whom the primary care provider contracts could result in a disruption in the provision of services to our members or a reduction in the services available to our members. Health care providers with which we contract may not properly manage the costs of services, maintain financial solvency or avoid disputes with other providers. They may also fail to provide us with the information we need to effectively conduct our businesses, such as information enabling us to estimate costs of care. Any of these events could have a material adverse effect on the provision of services to our members and our operations.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 8/26]
Some providers that render services to our members do not have contracts with us. In some instances, those providers may dispute the payment for these services and may institute litigation or arbitration relying on state and federal laws that define the compensation that must be paid to out-of-network providers in some circumstances.
The success of some of our businesses depends on maintaining satisfactory relationships with employed, affiliated, and independently contracted physicians and joint venture partners. The physicians who practice medicine or contract with our affiliated physician organizations could terminate their provider contracts or otherwise become unable or unwilling to continue practicing medicine or contracting with us. We face and will likely continue to face heightened competition to acquire or manage physician practices or to employ or contract with individual physicians. Our revenues could be materially and adversely affected if we are unable to maintain or expand satisfactory relationships with physicians, to acquire, recruit or, in some instances, employ physicians, or to retain enrollees following physician departures. In addition, our affiliated physician organizations contract with competitors of UnitedHealthcare. Our businesses could suffer if our affiliated physician organizations fail to maintain relationships with or fail to adequately price their contracts with these third-party payer competitors.
Further, physicians, hospitals, pharmaceutical benefit service providers, pharmaceutical manufacturers and certain health care providers are customers of our Optum businesses. Physicians also provide medical services at facilities owned by our Optum businesses. Given the importance of health care providers and other constituents to our businesses, failure to maintain satisfactory relationships with them could materially and adversely affect our results of operations, financial position and cash flows.
If we fail to compete effectively to maintain or increase our market share, including maintaining or increasing enrollments in businesses providing health benefits, our results of operations, financial position and cash flows
could be materially and adversely affected.
Our businesses face significant competition in all of the markets in which we operate. In many geographies or product segments, our competitors have and may continue to have certain competitive advantages. Our competitive position may also be adversely affected by significant merger and acquisition activity in the industries in which we operate, among both our competitors and suppliers. Consolidation among competitors may make it more difficult for us to retain or increase our customer base, maintain or improve the terms on which we do business with our suppliers, or maintain or increase our profitability.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 9/26]
In addition, our success in the health care marketplace and future growth depends on our ability to develop and deliver innovative and potentially disruptive products and services to satisfy evolving market demands. If we do not continue to innovate and provide products and services which are useful and relevant to health care payers, consumers and our customers, we may not remain competitive and risk losing market share to existing competitors and disruptive new market entrants. We may face risks from new technologies and market entrants which could affect our existing relationship with health plan enrollees in the affected markets. We could sustain competitive disadvantages and loss of market share if we fail to continue developing innovative care models, including by accelerating the transition of care to value-based models that achieve higher quality outcomes and better experiences at lower costs and expand access to virtual and in-home care. If health care payers or providers are unwilling or unable to enter into value-based agreements with us, we may be unable to successfully establish or maintain the contractual or employment relationships necessary to achieve the quality and cost objectives we have for value-based contracting. Additionally, our competitive position could be adversely affected by any failure to develop and apply innovative technologies and other effective data and analytics capabilities or to provide services to our clients focused on these technologies and capabilities.
Our business, results of operations, financial position and cash flows also could be materially and adversely affected if we do not compete effectively in our markets, if our reputation suffers harm, if we set rates too high or too low in highly competitive markets, if we do not design and price our products properly and competitively, if we are unable to innovate and deliver products and services demonstrating value to our customers, if we do not provide a satisfactory level of services, if membership or demand for other services does not increase as we expect or declines, or if we lose accounts with more profitable products while retaining or increasing membership in accounts with less profitable products.
We are routinely subject to various private party and governmental legal actions and investigations, which could damage our reputation and, if resolved unfavorably, could result in substantial penalties or monetary damages and materially and adversely affect our results of operations, financial position and cash flows.
We are routinely made party to a variety of private party and governmental legal actions and investigations related to, among other matters, the design, management and delivery of our product and service offerings. Any failure by us to adhere to the laws and regulations applicable to our businesses could subject us to civil and criminal penalties.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 10/26]
Legal actions to which we are a party have included and in the future could include matters related to health care benefits coverage and payment of claims (including disputes with enrollees, customers and contracted and non-contracted physicians, hospitals and other health care professionals), tort claims (including claims related to the delivery of health care services, such as medical malpractice by personnel at our affiliates’ facilities, or by health care practitioners who are employed by us, have contractual relationships with us, or serve as providers to our managed care networks, including as a result of a failure to adhere to applicable clinical, quality and/or patient safety standards), antitrust claims (including as a result of changes in the
enforcement of antitrust laws), whistleblower claims (including claims under the False Claims Act or similar statutes), matters related to our use of or alleged failure to adequately safeguard personal information or other proprietary data, claims related to alleged failure of our technology products to operate properly or fairly, contract and labor disputes, tax claims and claims related to disclosure of certain business practices. In addition, some of our pharmacy services operations are subject to clinical quality, patient safety and other risks inherent in the dispensing, packaging and distribution of drugs, including claims related to purported dispensing and other operational errors. We may also be party to certain class action lawsuits brought by health care professional groups and consumers. We operate in jurisdictions outside of the United States where contractual rights, tax positions and applicable regulations may be subject to interpretation or uncertainty to a greater degree than in the United States, and therefore subject to dispute by customers, government authorities or others.
We are largely self-insured with regard to litigation risks, including claims of medical malpractice against our affiliated physicians and us. Although we record liabilities for our estimates of the probable costs resulting from self-insured matters, it is possible the level of actual losses will significantly exceed the liabilities recorded. Additionally, physicians and other healthcare providers have become subject to an increasing number of legal actions alleging medical malpractice and general professional liabilities.
Even in states that have imposed caps on damages for such actions, litigants are seeking recoveries under theories of liability that might not be subject to the caps on damages. These actions involve significant defense costs and could result in substantial monetary damages or damage to our reputation.
---
SEC Filing: sec.gov/…↗
Accession: 0000731766-25-000063
Citation: mdck://UNH/0000731766-25-000063/risk_factors#c0
Chunk handles (cite the chunk a quoted figure came from):
c0 → mdck://UNH/0000731766-25-000063/risk_factors#c0
c1 → mdck://UNH/0000731766-25-000063/risk_factors#c1
c2 → mdck://UNH/0000731766-25-000063/risk_factors#c2
c3 → mdck://UNH/0000731766-25-000063/risk_factors#c3
c4 → mdck://UNH/0000731766-25-000063/risk_factors#c4
c5 → mdck://UNH/0000731766-25-000063/risk_factors#c5
c6 → mdck://UNH/0000731766-25-000063/risk_factors#c6
c7 → mdck://UNH/0000731766-25-000063/risk_factors#c7
c8 → mdck://UNH/0000731766-25-000063/risk_factors#c8
c9 → mdck://UNH/0000731766-25-000063/risk_factors#c9
›get_filing_section(cik="0000731766", section_id="risk_factors", offset=10)—Page 2 of 3
**Structured tables in this filing** — disaggregated figures behind this section's prose. Query these (not the prose) for the numbers:
- `table_debt_maturities` — Debt Maturities Schedule
- `table_deferred_taxes` — Deferred Tax Assets and Liabilities
- `table_fair_value` — Fair Value Measurements Schedule
- `table_goodwill` — Goodwill Schedule
- `table_ppe` — Property, Plant and Equipment Schedule
- `table_segment_reporting` — Segment Reporting Schedule
Or read the as-filed percentages directly: `get_xbrl_facts(cik="0000731766", search="concentration")` (revenue share by customer / channel / geography / product).
**Other sections in this filing:**
- `accountant_changes` (Changes in and Disagreements with Accountants) — ~14 words
- `business_description` (Business Description) — ~6,686 words
- `controls_procedures` (Controls and Procedures) — ~1,191 words
- `cybersecurity` (Cybersecurity) — ~790 words
- `footnote_accounting_policies` (Summary of Significant Accounting Policies) — ~3,700 words
- `footnote_cash_investments` (Cash and Investments) — ~894 words
- `footnote_commitments` (Commitments and Contingencies) — ~1,009 words
- `footnote_debt` (Debt and Credit Facilities) — ~1,852 words
- `footnote_derivatives` (Derivative Financial Instruments) — ~419 words
- `footnote_eps` (Earnings Per Share) — ~350 words
- `footnote_equity` (Stockholders' Equity) — ~976 words
- `footnote_fair_value` (Fair Value Measurements) — ~2,572 words
- `footnote_goodwill` (Goodwill and Intangible Assets) — ~1,387 words
- `footnote_income_tax` (Income Taxes) — ~2,762 words
- `footnote_leases` (Leases) — ~111 words
- `footnote_pension` (Pension and Post-Retirement Benefits) — ~65 words
- `footnote_ppe` (Property, Plant and Equipment) — ~4,091 words
- `footnote_revenue` (Revenue Recognition) — ~1,078 words
- `footnote_segment` (Segment Information) — ~3,117 words
- `footnote_stock_comp` (Stock-Based Compensation) — ~1,825 words
- `footnotes_introduction` (Notes to Financial Statements - Introduction) — ~83 words
- `legal_proceedings` (Legal Proceedings) — ~54 words
- `market_equity` (Market for Common Equity) — ~239 words
- `market_risk` (Market Risk Disclosures) — ~431 words
- `mda_critical_accounting` (Critical Accounting Policies)
- `mda_full` (Management's Discussion and Analysis) — ~22,613 words
- `mda_liquidity` (Liquidity and Capital Resources)
- `mda_outlook`
- `mda_results_operations` (Results of Operations)
- `mine_safety` (Mine Safety Disclosures) — ~6 words
- `other_information_10k` (Other Information (10-K)) — ~66 words
- `policy_cash_equivalents` (Cash and Cash Equivalents Policy) — ~42 words
- `policy_consolidation` (Consolidation Policy) — ~30 words
- `policy_fair_value` (Fair Value Measurement Policy) — ~917 words
- `policy_leases` (Leases Policy) — ~111 words
- `policy_ppe` (Property, Plant and Equipment Policy) — ~130 words
- `policy_receivables` (Receivables and Credit Loss Policy) — ~172 words
- `policy_revenue_recognition` (Revenue Recognition Policy) — ~1,078 words
- `properties` (Properties) — ~442 words
- `risk_factors_risks_related_to_our_business_and_our_industry`
- `risk_factors_risks_related_to_the_regulation_of_our_business`
- `signature_officers` (Signatures (Executive Officers)) — ~489 words
- `table_debt_maturities` (Debt Maturities Schedule) — ~64 words
- `table_deferred_taxes` (Deferred Tax Assets and Liabilities) — ~359 words
- `table_fair_value` (Fair Value Measurements Schedule) — ~658 words
- `table_goodwill` (Goodwill Schedule) — ~236 words
- `table_ppe` (Property, Plant and Equipment Schedule) — ~42 words
- `table_segment_reporting` (Segment Reporting Schedule) — ~1,994 words
- `unresolved_staff_comments` (Unresolved Staff Comments) — ~10 words
_Drill in via `get_filing_section(cik="0000731766", accession_number="0000731766-25-000063", section_id="...")`._
19Thinking
I have the first 10 chunks of each risk factors section. The FY2025 10-K has 25 chunks and the FY2024 10-K has 26 chunks, so there's much more to read. I need to get the remaining chunks to do a thorough comparison, particularly to find any NEW risks added in FY2025 vs FY2024. Let me get the next pages for both filings simultaneously to see the rest of the risk factors.
Let me fetch pages 2 (offset=10) for both filings.
Looking at the first 10 chunks from both years:
- Medical cost estimation/pricing risk — BOTH
- Data/IT system integrity risk — BOTH
- AI/technology risk — BOTH (FY2025 drops the ML suffix, just says "AI", and expands the language)
- Cybersecurity/Change Healthcare breach — BOTH
- Provider relationship risk — BOTH
- Competition risk — BOTH
- Legal actions/litigation risk — BOTH
I'm noticing some key differences already: FY2025 chunk 2 added "increased provider billing intensity" as a medical cost factor that wasn't in FY2024, and chunk 3 shifts from "artificial intelligence and machine learning (AI/ML)" to just "artificial intelligence (AI)" while adding language about incomplete or outdated data.
FY2025 also uses "fully-integrated fashion" versus FY2024's "seamless fashion" for technology products, and the cyberattack description becomes more specific with "misappropriation or disclosure" rather than just "disclosure." The threat actor language gets more granular too—FY2025 specifically mentions "AI technologies (including generative AI)" and lists out "viruses, ransomware and malware, among others" more explicitly, plus adds "insider threat" to the risk factors.
I also notice FY2025 chunk 10 expands the class action lawsuit language to include "investors" alongside health care professional groups and consumers. I should pull the next section of both documents to see if there are entirely new risk factor categories introduced.
20Narration
Good start — I can see the first 10 chunks of each. I need to page through the rest to catch any new risk headings added in FY2025. Let me pull the second and third pages of both in parallel.
21Tool call·get_filing_section
{
"ticker": "UNH",
"section_id": "risk_factors",
"accession_number": "0000731766-26-000062",
"offset": 10,
"max_chars": 30000
}
22Tool call·get_filing_section
{
"ticker": "UNH",
"section_id": "risk_factors",
"accession_number": "0000731766-25-000063",
"offset": 10,
"max_chars": 30000
}
23Result·get_filing_section✓ ok · 29,978 ch
# UNH — risk_factors
10-K FY FY2024 (filed 2025-02-27)
~9,646 words | Chunks 11-20 of 26
[UNH | 10-K FY 2024 | Risk Factors | Chunk 11/26]
We cannot predict the outcome of significant legal actions in which we are involved. Even in situations where we engage external insurers, our coverage may be disputed or may not be sufficient to cover the entirety of certain claims. We incur expenses to resolve these matters and current and future legal actions could further increase our cost of doing business, require us to potentially change the way we conduct our business, and materially and adversely affect our results of operations, financial position and cash flows. Moreover, certain legal actions could result in adverse publicity which could damage our reputation and materially and adversely affect our ability to retain our current business or grow our market share in some markets and businesses.
Our business could suffer, and our results of operations, financial position and cash flows could be materially and adversely affected, if we fail to successfully manage our strategic alliances, or to complete, manage or integrate acquisitions and other significant strategic transactions or relationships.
As part of our business strategy, we frequently engage in discussions with third parties regarding possible investments, acquisitions, divestitures, strategic alliances, joint ventures and outsourcing transactions and often enter into agreements relating to such transactions. If we fail to meet the needs of our alliance or joint venture partners, including by developing additional products and services, providing high levels of service, pricing our products and services competitively or responding effectively to applicable federal and state regulatory changes, our alliances and joint ventures could be damaged or terminated, which in turn could adversely impact our reputation, business and results of operations. Further, governmental actions, such as actions by the FTC or DOJ, may affect our ability to complete strategic transactions, which could adversely affect our future growth. If we fail to identify and successfully complete transactions to meet our strategic objectives, including as a result of antitrust regulatory enforcement actions, such as those that have been brought against us in the past, we may be required to expend resources to develop products and technology internally, be placed at a competitive disadvantage or be adversely affected by negative market perceptions, any of which may have a material adverse effect on our results of operations, financial position or cash flows.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 12/26]
Successful acquisitions also require us to effectively integrate the acquired business into our existing operations, including our internal control environment and culture, or otherwise leveraging its operations which may present risks different from those presented by organic growth and may be difficult for us to manage. For example, we have experienced and in the future may encounter more acute information technology system vulnerabilities or different litigation risk profiles in recently acquired business than we have historically managed. We may be unable to address such vulnerabilities, inadequacies, differences, or failures soon after acquiring a business, which could undermine integration activities, delay launch of acquired products, and increase infrastructure risk. In addition, even with appropriate diligence, pre-acquisition practices of an acquired business have exposed us in the past and may expose us in the future to legal challenges and investigations that could subject us to criminal fines or reputational harm. Even if we are ultimately successful in resolving these matters, defending such claims may be costly and result in negative publicity. If we cannot successfully integrate our acquired businesses and realize contemplated revenue growth opportunities, cost savings and other synergies, our business, prospects, results of operations, financial position and cash flows could be materially and adversely affected.
We are subject to risks associated with public health crises arising from large-scale medical emergencies, pandemics, natural disasters and other extreme events, which have had and could have an adverse effect on our business, results of operations, financial condition and financial performance.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 13/26]
Large-scale medical emergencies, pandemics, natural disasters, public health crises and other extreme events could have a material adverse effect on our business operations, cash flows, financial conditions and results of operations. For example, disruptions in public and private infrastructure resulting from such events could increase our operating costs and impair our ability to provide services to our clients and customers. In addition, as a result of these events, the premiums and fees we charge may not be sufficient to cover our medical and administrative costs, deferred medical care could be sought in future periods at potentially higher acuity levels, we could experience reduced demand for our services, and our clinical and non-clinical workforce could be affected and sustain a reduced capacity to handle demand for care. Public health crises arising from natural disasters, such as wildfires, hurricanes, and snowstorms, or effects of climate change could impact our business operations and result in increased medical care costs. Government enactment of emergency powers in response to public health crises could disrupt our business operations, including by restricting availability of, or our ability to deliver, pharmaceuticals or other supplies, and could increase the risk of shortages of necessary items.
Our sales performance will suffer if we do not adequately attract, retain and provide support to a network of independent producers and consultants.
Our products and services are sold in part through nonexclusive producers and consultants for whose services and allegiance we must compete. Our sales could be materially and adversely affected if we are unable to attract, retain and support independent producers and consultants or if our sales strategy is not appropriately aligned across distribution channels. Our relationships with producers could be impaired by changes in our business practices and the terms of our relationships, including commission levels.
Our businesses are subject to risks associated with unfavorable economic conditions.
Unfavorable economic conditions may have a range of impacts on the demand for our products and services. Such conditions also have caused and in future periods could continue to cause employers to stop offering certain health care coverage as an employee benefit or elect to offer particular coverage on a voluntary, employee-funded basis to reduce their operating costs. In addition, unfavorable economic conditions could adversely impact our ability to increase premiums or result in the cancellation by certain customers of our products and services. These conditions could lead to a decrease in people served and in the premium and fee revenues we generate.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 14/26]
A prolonged unfavorable economic environment could constrain state and federal budgets and result in reduced reimbursements or payments in our federal and state government health care coverage programs, including Medicare, Medicaid and CHIP. A reduction in state Medicaid reimbursement rates could be implemented retroactively to apply to payments already negotiated or received from the government. In addition, state and federal budgetary pressures could cause the affected governments to impose new or a higher level of taxes or assessments for our commercial programs, such as premium taxes on health insurance and surcharges or fees on select fee-for-service and capitated medical claims. Any of these developments or actions could materially and adversely affect our results of operations, financial position and cash flows.
A prolonged unfavorable economic environment could also adversely impact the financial position of hospitals and other care providers which could negatively affect our contracted rates with these parties and increase our medical costs or materially and adversely affect their ability to purchase our service offerings. Further, unfavorable economic conditions could have a material adverse effect on our financial results by impacting the customers of our Optum businesses, including health plans, hospitals, care providers, employers and others.
Our failure to attract, develop, retain, and manage the succession of key employees and executives could adversely affect our business, results of operations and future performance.
We depend on our ability to attract, develop and retain qualified employees and executives, including those with diverse talents, backgrounds, experiences and perspectives, to operate and expand our business. While we have development and succession plans in place for our key employees and executives, these plans do not guarantee that the services of our key employees and executives will continue to be available to us. If we are unable to attract, develop, retain and effectively manage the development and succession plans for key employees and executives, our business, results of operations and future performance could be adversely affected. Experienced and highly skilled employees and executives in the health care and technology industries are in high demand and the market for their services is competitive. We may have difficulty in replacing key executives because of the limited number of qualified individuals in these industries with the breadth of skills and experience required to operate and successfully expand our business. Adverse changes to our corporate culture could harm our business operations and our ability to retain key employees and executives.
Our investment portfolio may sustain losses which could adversely affect our profitability.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 15/26]
Market fluctuations could impair the value of our investment portfolio and our profitability. Volatility in interest rates affects our interest income and the market value of our investments in debt securities of varying maturities which constitute the substantial majority of the fair value of our investments as of December 31, 2024. In addition, a delay in payment of principal or interest by issuers, or defaults by issuers (primarily issuers of our investments in corporate and municipal bonds), could reduce our investment income and require us to write down the value of our investments which could adversely affect our profitability and equity.
Our investments may not produce total positive returns and we may sell investments at prices which are less than their carrying values. Changes in the value of our investment assets, as a result of interest rate fluctuations, changes in issuer financial or market conditions, illiquidity or otherwise, could have an adverse effect on our equity. In addition, if it should become necessary for us to liquidate a material portion of our investment portfolio on an accelerated basis, such an action could have an adverse effect on our results of operations and the capital position of our regulated subsidiaries.
If the value of our intangible assets is materially impaired, our results of operations, equity and credit ratings could be materially and adversely affected.
As of December 31, 2024, our goodwill and other intangible assets had a carrying value of $130 billion, representing 44% of our total consolidated assets. We periodically evaluate our goodwill and other intangible assets to determine whether all or a portion of their carrying values may be impaired, in which case a charge to earnings may be necessary. The value of our goodwill may be materially and adversely impacted if businesses we acquire perform in a manner inconsistent with our assumptions. In addition, from time to time we divest businesses, and any such divestiture could result in significant asset impairment and disposition charges, including those related to goodwill and other intangible assets. Any future evaluations requiring an impairment of our goodwill and other intangible assets could materially and adversely affect our results of operations and equity in the period in which the impairment occurs. A material decrease in equity could, in turn, adversely affect our credit ratings.
If we are not able to protect our proprietary rights to our databases, software and related products, or other intellectual property, our ability to market our knowledge and information-related businesses could suffer.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 16/26]
We rely on our agreements with customers, confidentiality agreements with employees and third parties, and our trademarks, trade secrets, copyrights and patents to protect our proprietary rights. These legal protections and precautions may not prevent misappropriation of our proprietary information. In addition, intellectual property rights inherent in software are the subject of substantial litigation, and we expect our software products to be increasingly subject to third-party infringement claims as the number of products and competitors in the health care-focused software industry segment grows. Such litigation and misappropriation of our proprietary information could hinder our ability to market and sell products and services which could materially and adversely affect our results of operations, financial position and cash flows.
Any downgrades in our credit ratings could increase our borrowing and operating costs.
Claims paying ability, financial strength and debt ratings by nationally recognized statistical rating organizations are important factors in establishing the competitive position of insurance companies. Ratings information is broadly disseminated and generally used by customers and creditors. We believe our claims paying ability and financial strength ratings are important factors in marketing our products to certain of our customers. Our credit ratings impact both the cost and availability of future borrowings. Each of the credit rating agencies reviews its ratings periodically. Our ratings reflect each credit rating agency’s opinion of our financial strength, operating performance and ability to meet our debt obligations or obligations to policyholders. We may not be able to maintain our current credit ratings in the future. Any downgrades in our credit ratings could materially increase our costs of or ability to access funds in the debt capital markets and otherwise materially increase our operating costs.
Risks Related to the Regulation of Our Business
Our business activities in the United States and other countries are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could materially and adversely affect our business.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 17/26]
We are regulated by federal, state and local governments in the United States and other countries where we do business. Our insurance and HMO subsidiaries must be licensed by and are subject to regulation in the jurisdictions in which they conduct business. For example, states require periodic financial reports and enforce minimum capital or restricted cash reserve requirements. Health plans and insurance companies are also regulated under state insurance holding company regulations and some of our activities may be subject to other health care-related regulations and requirements, including regulations and licensure requirements related to PPOs, MCOs, UR and TPAs. Under state guaranty association laws, certain insurance companies can be assessed (up to prescribed limits) for certain obligations to the policyholders and claimants of impaired or insolvent insurance companies which write the same line or similar lines of business. Any such assessment could expose our
insurance entities and other insurers to the risk they would be required to pay a portion of an impaired or insolvent insurance company’s claims through state guaranty associations.
Some of our businesses provide products or services to government agencies. For example, some of our Optum and UnitedHealthcare businesses hold government contracts or provide services related to government contracts and are subject to U.S. federal and state and non-U.S. self-referral, anti-kickback, medical necessity, risk adjustment, false claims and other laws and regulations governing government contractors and the use of government funds. Our relationships with these government agencies are subject to the terms of our contracts with the agencies and to laws and regulations regarding government contracts. Among others, certain laws and regulations restrict or prohibit companies from performing work for government agencies which might be viewed to involve an actual or potential conflict of interest. These laws and regulations may limit our ability to pursue and perform certain types of engagements, thereby materially and adversely affecting our results of operations, financial position and cash flows.
Some of our Optum businesses are also subject to regulations distinct from those faced by our insurance and HMO subsidiaries, some of which could impact our relationships with physicians, hospitals and customers. These regulations include state telemedicine regulations; debt collection laws; banking regulations; distributor and producer licensing requirements; state corporate practice of medicine restrictions; fee-splitting rules; and health care facility licensure and certificate of need requirements. These risks and uncertainties may materially and adversely affect our ability to market or provide our products and services, or to achieve targeted operating margins, or may increase the regulatory burdens under which we operate.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 18/26]
The laws and rules governing our businesses and interpretations of those laws and rules are subject to frequent and often unpredictable change. For example, legislative, administrative and public policy changes to the ACA have been and likely will continue to be considered, and we cannot predict if the ACA will be further modified. Additionally, changes in tax laws or unfavorable resolutions of exams could create additional tax liabilities.
The integration of entities we acquire into our businesses may affect the way in which existing laws and rules apply to us, including by subjecting us to laws and rules which did not previously apply to us. The broad latitude given to the agencies administering, interpreting and enforcing current and future regulations governing our businesses could compel us to change how we do business, renegotiate existing contracts and other arrangements, restrict revenue and enrollment growth, increase our health care and administrative costs and capital requirements, or expose us to increased liability in courts for coverage determinations, resolution of commercial disputes and other actions.
We also must obtain and maintain regulatory approvals to market many of our products and services, increase prices for some regulated products and services and complete or integrate strategic transactions. For example, premium rates for our health insurance and managed care products are subject to regulatory review or approval in many states and by the federal government. Additionally, we must submit data on proposed rate increases to HHS on many of our products for monitoring purposes. Geographic and product expansions of our businesses may be subject to state and federal regulatory approvals. Delays in obtaining necessary approvals or our failure to obtain or maintain adequate approvals could materially and adversely affect our results of operations, financial position and cash flows.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 19/26]
We also currently operate outside of the United States and in the future may acquire or commence additional businesses based outside of the United States, increasing our exposure to non-U.S. regulatory regimes. Our failure to comply with U.S. or non-U.S. laws and regulations governing our conduct outside the United States or to establish constructive relationships with non-U.S. regulators could adversely affect our ability to market our products and services or to do so at targeted operating margins, which may have a material adverse effect on our business, financial condition and results of operations. Non-U.S. regulatory regimes, which vary by jurisdiction, encompass, among other matters, local and cross-border taxation, licensing, tariffs, intellectual property, investment, capital (including minimum solvency margin and reserve requirements), management control, labor, anti-fraud, anti-corruption and privacy and data protection regulations (including requirements for cross-border data transfers). Any foreign regulator or court may take an approach to the interpretation, implementation and enforcement of industry regulations which could differ from the approach taken by U.S. regulators or courts. In addition, our non-U.S. businesses and operations are subject to U.S. laws regulating the conduct and activities of U.S.-based businesses operating outside the United States, such as the FCPA, which prohibits offering, promising, providing or authorizing others to give anything of value to a foreign government official to obtain or retain business or otherwise secure a business advantage.
The health care industry is regularly subject to negative publicity, including as a result of governmental investigations, adverse media coverage and political debate concerning industry regulation. Negative publicity may adversely affect our stock price, damage our reputation, and expose us to unexpected or unwarranted regulatory scrutiny.
As a result of our participation in various government health care programs, both as a payer and as a service provider to payers, we are exposed to additional risks associated with program funding, enrollments, payment adjustments, audits and government investigations which could materially and adversely affect our business, results of operations, financial position and cash flows.
We participate in various federal, state and local government health care benefit programs, including as a payer in Medicare Advantage, Medicare Part D, various Medicaid programs and CHIP, and receive substantial revenues from these programs. Some of our Optum businesses also provide services to payers participating in government health care programs. A reduction or less than expected increase, or a protracted delay, in government funding for these programs or change in allocation methodologies, or termination of the contract at the option of the government, has affected and in future periods may materially and adversely affect our results of operations, financial position and cash flows.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 20/26]
The government health care programs in which we participate are generally subject to frequent changes, including changes which may reduce the number of persons enrolled or eligible for coverage (such as Medicaid eligibility redeterminations in certain states), reduce the amount of reimbursement or payment levels, reduce our participation in, or prevent our expansion into, certain service areas or markets, or increase our administrative or medical costs under such programs. Revenues for these programs depend on periodic funding from the federal government or applicable state governments and allocation of the funding through various payment mechanisms. Funding for these government programs depends on many factors outside of our control, including general economic conditions and budgetary constraints at the federal or applicable state level. For example, CMS in the past has reduced or frozen Medicare Advantage benchmarks and additional cuts to Medicare Advantage benchmarks are possible. In addition, from time to time, CMS makes changes to the way it calculates Medicare Advantage risk adjustment payments. Although we have adjusted members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and operating cost management in response to the benchmark reductions and other funding pressures, these or other strategies may not fully address the funding pressures in the Medicare Advantage program. In addition, payers in the Medicare Advantage program may be subject to reductions in payments from CMS as a result of decreased funding or recoupment pursuant to government audit. States have also made changes in rates and reimbursements for Medicaid members and audits can result in unexpected recoupments.
---
SEC Filing: sec.gov/…↗
Accession: 0000731766-25-000063
Citation: mdck://UNH/0000731766-25-000063/risk_factors#c10
Chunk handles (cite the chunk a quoted figure came from):
c10 → mdck://UNH/0000731766-25-000063/risk_factors#c10
c11 → mdck://UNH/0000731766-25-000063/risk_factors#c11
c12 → mdck://UNH/0000731766-25-000063/risk_factors#c12
c13 → mdck://UNH/0000731766-25-000063/risk_factors#c13
c14 → mdck://UNH/0000731766-25-000063/risk_factors#c14
c15 → mdck://UNH/0000731766-25-000063/risk_factors#c15
c16 → mdck://UNH/0000731766-25-000063/risk_factors#c16
c17 → mdck://UNH/0000731766-25-000063/risk_factors#c17
c18 → mdck://UNH/0000731766-25-000063/risk_factors#c18
c19 → mdck://UNH/0000731766-25-000063/risk_factors#c19
›get_filing_section(cik="0000731766", section_id="risk_factors", offset=20)—Page 3 of 3
**Structured tables in this filing** — disaggregated figures behind this section's prose. Query these (not the prose) for the numbers:
- `table_debt_maturities` — Debt Maturities Schedule
- `table_deferred_taxes` — Deferred Tax Assets and Liabilities
- `table_fair_value` — Fair Value Measurements Schedule
- `table_goodwill` — Goodwill Schedule
- `table_ppe` — Property, Plant and Equipment Schedule
- `table_segment_reporting` — Segment Reporting Schedule
Or read the as-filed percentages directly: `get_xbrl_facts(cik="0000731766", search="concentration")` (revenue share by customer / channel / geography / product).
**Other sections in this filing:**
- `accountant_changes` (Changes in and Disagreements with Accountants) — ~14 words
- `business_description` (Business Description) — ~6,686 words
- `controls_procedures` (Controls and Procedures) — ~1,191 words
- `cybersecurity` (Cybersecurity) — ~790 words
- `footnote_accounting_policies` (Summary of Significant Accounting Policies) — ~3,700 words
- `footnote_cash_investments` (Cash and Investments) — ~894 words
- `footnote_commitments` (Commitments and Contingencies) — ~1,009 words
- `footnote_debt` (Debt and Credit Facilities) — ~1,852 words
- `footnote_derivatives` (Derivative Financial Instruments) — ~419 words
- `footnote_eps` (Earnings Per Share) — ~350 words
- `footnote_equity` (Stockholders' Equity) — ~976 words
- `footnote_fair_value` (Fair Value Measurements) — ~2,572 words
- `footnote_goodwill` (Goodwill and Intangible Assets) — ~1,387 words
- `footnote_income_tax` (Income Taxes) — ~2,762 words
- `footnote_leases` (Leases) — ~111 words
- `footnote_pension` (Pension and Post-Retirement Benefits) — ~65 words
- `footnote_ppe` (Property, Plant and Equipment) — ~4,091 words
- `footnote_revenue` (Revenue Recognition) — ~1,078 words
- `footnote_segment` (Segment Information) — ~3,117 words
- `footnote_stock_comp` (Stock-Based Compensation) — ~1,825 words
- `footnotes_introduction` (Notes to Financial Statements - Introduction) — ~83 words
- `legal_proceedings` (Legal Proceedings) — ~54 words
- `market_equity` (Market for Common Equity) — ~239 words
- `market_risk` (Market Risk Disclosures) — ~431 words
- `mda_critical_accounting` (Critical Accounting Policies)
- `mda_full` (Management's Discussion and Analysis) — ~22,613 words
- `mda_liquidity` (Liquidity and Capital Resources)
- `mda_outlook`
- `mda_results_operations` (Results of Operations)
- `mine_safety` (Mine Safety Disclosures) — ~6 words
- `other_information_10k` (Other Information (10-K)) — ~66 words
- `policy_cash_equivalents` (Cash and Cash Equivalents Policy) — ~42 words
- `policy_consolidation` (Consolidation Policy) — ~30 words
- `policy_fair_value` (Fair Value Measurement Policy) — ~917 words
- `policy_leases` (Leases Policy) — ~111 words
- `policy_ppe` (Property, Plant and Equipment Policy) — ~130 words
- `policy_receivables` (Receivables and Credit Loss Policy) — ~172 words
- `policy_revenue_recognition` (Revenue Recognition Policy) — ~1,078 words
- `properties` (Properties) — ~442 words
- `risk_factors_risks_related_to_our_business_and_our_industry`
- `risk_factors_risks_related_to_the_regulation_of_our_business`
- `signature_officers` (Signatures (Executive Officers)) — ~489 words
- `table_debt_maturities` (Debt Maturities Schedule) — ~64 words
- `table_deferred_taxes` (Deferred Tax Assets and Liabilities) — ~359 words
- `table_fair_value` (Fair Value Measurements Schedule) — ~658 words
- `table_goodwill` (Goodwill Schedule) — ~236 words
- `table_ppe` (Property, Plant and Equipment Schedule) — ~42 words
- `table_segment_reporting` (Segment Reporting Schedule) — ~1,994 words
- `unresolved_staff_comments` (Unresolved Staff Comments) — ~10 words
_Drill in via `get_filing_section(cik="0000731766", accession_number="0000731766-25-000063", section_id="...")`._
24Result·get_filing_section✓ ok · 31,886 ch
# UNH — risk_factors
10-K FY FY2025 (filed 2026-03-02)
~7,575 words | Chunks 11-20 of 25
[UNH | 10-K FY 2025 | Risk Factors | Chunk 11/25]
We cannot predict the outcome of significant legal actions in which we are involved. Even in situations where we engage external insurers, our coverage may be disputed or may not be sufficient to cover the entire amount of certain claims. We incur expenses to resolve these matters and current and future legal actions could further increase our cost of doing business, require us to potentially change the way we conduct our business, and materially and adversely affect our results of operations, financial position and cash flows. Moreover, certain legal actions could result in adverse publicity which could damage our reputation and materially and adversely affect our ability to retain our current business or grow our market share in some markets and businesses.
Our increasing use of AI presents legal, regulatory and business risks to our operations, reputation and financial results.
We increasingly rely on technologies powered by or incorporating AI in our internal operations and in the delivery of products and services. While these technologies present opportunities to improve efficiency, enhance customer experience, and optimize clinical and administrative processes, they also entail risks and uncertainties.
We have developed and implemented policies and procedures intended to promote and sustain the responsible design, development, and use of these technologies, consistent with industry best practices. However, to the extent an AI system does not operate as intended or produces an inaccurate, incomplete or biased output, the system could impact operations, customer service or other functions and could have an adverse effect on our business, reputation, results of operations, financial position and cash flows.
Our business could suffer, and our results of operations, financial position and cash flows could be materially and adversely affected, if we fail to successfully manage our strategic alliances, or to complete, manage or integrate acquisitions and other significant strategic transactions or relationships.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 12/25]
As part of our business strategy, we frequently engage in discussions with third parties regarding possible investments, acquisitions, divestitures, strategic alliances, joint ventures and outsourcing transactions and often enter into agreements relating to such transactions. If we fail to meet the needs of our alliance or joint venture partners, including by developing additional products and services, providing high levels of service, pricing our products and services competitively or responding effectively to applicable federal and state regulatory changes, our alliances and joint ventures could be damaged or terminated, which in turn could adversely impact our reputation, business and results of operations. Further, governmental actions, such as actions by the FTC or DOJ or comparable non-U.S. regulatory bodies, may affect our ability to complete strategic transactions, which could adversely affect our future growth. If we fail to identify and successfully complete transactions to meet our strategic objectives, including as a result of antitrust regulatory enforcement actions, such as those that have been brought against us in the past, we may be required to expend resources to develop products and technology internally, be placed at a competitive disadvantage or be adversely affected by negative market perceptions, any of which may have a material adverse effect on our results of operations, financial position or cash flows.
Successful acquisitions also require us to effectively, comprehensively and expeditiously integrate the acquired business into our existing operations, including our internal control environment and culture, or otherwise leverage its operations which may present risks different from those presented by organic growth and may be difficult for us to manage. For example, we have experienced and in the future may encounter more acute information technology system vulnerabilities or different litigation risk profiles in recently acquired businesses than we have historically managed. We may be unable to address these vulnerabilities, inadequacies, differences, or failures soon after acquiring a business, which could undermine integration activities, delay launch of acquired products, and increase infrastructure risk. In addition, even with appropriate diligence, pre-acquisition practices of an acquired business have exposed us in the past and may expose us in the future to legal challenges and investigations that could subject us to criminal fines or reputational harm. Even if we are ultimately successful in resolving these matters, defending such claims may be costly and result in negative publicity. If we cannot successfully integrate our acquired businesses and realize contemplated revenue growth opportunities, cost savings and other synergies, our business, prospects, results of operations, financial position and cash flows could be materially and adversely affected.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 13/25]
We are subject to risks associated with public health crises arising from large-scale medical emergencies, pandemics, natural disasters and other extreme events, which have had and could have an adverse effect on our business, results of operations, financial condition and financial performance.
Large-scale medical emergencies, pandemics, natural disasters, public health crises and other extreme events could have a material adverse effect on our business operations, cash flows, financial conditions and results of operations. For example, disruptions in public and private infrastructure resulting from such events could increase our operating costs and impair our ability to provide services to our clients and customers. In addition, as a result of these events, the premiums and fees we charge may not be sufficient to cover our medical and administrative costs, deferred medical care could be sought in future periods at potentially higher acuity levels, we could experience reduced demand for our services, and our clinical and non-clinical workforce could be affected and sustain a reduced capacity to handle demand for care. Public health crises arising from natural disasters, such as wildfires, hurricanes, and snowstorms, or effects of climate change could impact our business operations and result in increased medical care costs. Government enactment of emergency powers in response to public health crises could disrupt our business operations, including by restricting availability of, or our ability to deliver, pharmaceuticals or other medical supplies, and could increase the risk of shortages of necessary items.
Our sales performance will suffer if we do not adequately attract, retain and provide support to a network of independent producers and consultants.
Our products and services are sold in part through nonexclusive producers and consultants for whose services and allegiance we must compete. Our sales could be materially and adversely affected if we are unable to attract, retain and support independent producers and consultants or if our sales strategy is not appropriately aligned across distribution channels. Our relationships
with producers could be impaired by changes in our business practices and the terms of our relationships, including commission levels.
Our businesses are subject to risks associated with unfavorable economic conditions.
Unfavorable economic conditions may have a range of impacts on the demand for our products and services. Such conditions also have caused and in future periods could continue to cause employers to stop offering certain health care coverage as an employee benefit or elect to offer particular coverage on a voluntary, employee-funded basis to reduce their operating costs. In addition, unfavorable economic conditions could adversely impact our ability to increase premiums or result in the cancellation by certain customers of our products and services. These conditions could lead to a decrease in people served and in the premium and fee revenues we generate.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 14/25]
A prolonged unfavorable economic environment could constrain state and federal budgets and result in reduced reimbursements or payments in our federal and state government health care coverage programs, including Medicare, Medicaid and CHIP. A reduction in state Medicaid reimbursement rates could be implemented retroactively to apply to payments already negotiated or received from the government. In addition, state and federal budgetary pressures could cause the affected governments to impose new or a higher level of taxes or assessments for our commercial programs, such as premium taxes on health insurance and surcharges or fees on select fee-for-service and capitated medical claims. Any of these developments or actions could materially and adversely affect our results of operations, financial position and cash flows.
A prolonged unfavorable economic environment could also adversely impact the financial position of hospitals and other care providers, which could negatively affect our contracted rates with these parties and increase our medical costs or materially and adversely affect their ability to purchase our service offerings. Further, unfavorable economic conditions could have a material adverse effect on our financial results by impacting the customers of our Optum businesses, including health plans, hospitals, care providers, employers and others.
Our failure to attract, develop, retain, and manage the succession of key employees and executives could adversely affect our business, results of operations and future performance.
We depend on our ability to attract, develop and retain qualified employees and executives, including those with diverse talents, backgrounds, experiences and perspectives, to operate and expand our business. While we have development and succession plans in place for our key employees and executives, these plans do not guarantee that the services of our key employees and executives will continue to be available to us. If we are unable to attract, develop, retain and effectively manage the development and succession plans for key employees and executives, our business, results of operations and future performance could suffer. Experienced and highly skilled employees and executives in the health care and technology industries are in high demand and the market for their services is competitive. We may have difficulty in replacing key executives because of the limited number of qualified individuals in these industries with the breadth of skills and experience required to operate and successfully expand our business. Further, the increased availability of hybrid or remote working arrangements has expanded the pool of companies that can compete for qualified employees and executive candidates. Adverse changes to our corporate culture could harm our business operations and our ability to retain key employees and executives.
Our investment and loan portfolio may sustain losses which could adversely affect our profitability.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 15/25]
Market fluctuations could impair the value of our investment and loan portfolio and our profitability. Volatility in interest rates affects our interest income and the market value of our investments in debt securities of varying maturities which constitute the substantial majority of the fair value of our investments as of December 31, 2025. In addition, a delay in payment of principal or interest by issuers or other borrowers, or defaults by issuers (primarily issuers of our investments in corporate and municipal bonds) or other borrowers, could reduce our investment income and require us to write down the value of our investments or loans, which could adversely affect our profitability and equity.
Our investments may not produce total positive returns and we may sell investments at prices which are less than their carrying values. Changes in the value of our investment assets, as a result of interest rate fluctuations, changes in issuer financial or market conditions, illiquidity or otherwise, could have an adverse effect on our equity interests. In addition, if it should become necessary for us to liquidate a material portion of our investment and loan portfolio on an accelerated basis, such an action could have an adverse effect on our results of operations and the capital position of our regulated subsidiaries.
If the value of our intangible assets is materially impaired, our results of operations, equity and credit ratings could be materially and adversely affected.
As of December 31, 2025, our goodwill and other intangible assets had a carrying value of $131 billion, representing 42% of our total consolidated assets. We periodically evaluate our goodwill and other intangible assets to determine whether all or a portion of their carrying values may be impaired, in which case a charge to earnings may be necessary. The value of our goodwill may be materially and adversely impacted if businesses we acquire perform in a manner inconsistent with our assumptions. In addition, we divest businesses from time to time, and any such divestiture could result in significant asset
impairment and disposition charges, including those related to goodwill and other intangible assets. Any future evaluations requiring an impairment of our goodwill and other intangible assets could materially and adversely affect our results of operations and equity in the period in which the impairment occurs. A material decrease in equity value could, in turn, adversely affect our credit ratings.
If we are not able to protect our proprietary rights to our databases, software and related products, or other intellectual property, our ability to market our knowledge and information-related businesses could suffer.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 16/25]
We rely on our agreements with customers, confidentiality agreements with employees and third parties, and our trademarks, trade secrets, copyrights and patents to protect our proprietary rights. These legal protections and precautions may not prevent misappropriation of our proprietary information. In addition, intellectual property rights inherent in software are the subject of substantial litigation, and we expect our software products to be increasingly subject to third-party infringement claims as the number of products and competitors in the health care-focused software industry segment grows. Such litigation and misappropriation of our proprietary information could hinder our ability to market and sell products and services, which could materially and adversely affect our results of operations, financial position and cash flows.
Any downgrades in our credit ratings could increase our borrowing and operating costs.
Claims paying ability, financial strength and debt ratings by nationally recognized statistical rating organizations are important factors in establishing the competitive position of insurance companies. Ratings information is broadly disseminated and generally used by customers and creditors. We believe our claims paying ability and financial strength ratings are important factors in marketing our products to certain of our customers. Our credit ratings impact both the cost and availability of future borrowings. Each of the credit rating agencies reviews its ratings periodically. Our ratings reflect each credit rating agency’s opinion of our financial strength, operating performance and ability to meet our debt obligations or obligations to policyholders. We have been the subject of downgrades and other negative credit rating actions in past periods, and may not be able to maintain our current credit ratings in future periods. Any downgrades in our credit ratings could materially increase our costs of or ability to access funds in the debt capital markets and otherwise materially increase our operating costs.
Risks Related to the Regulation of Our Business
Our business activities in the United States and other countries are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could materially and adversely affect our business.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 17/25]
We are regulated by federal, state and local governments in the United States and other countries where we do business. Our insurance and HMO subsidiaries must be licensed by and are subject to regulation in the jurisdictions in which they conduct business. For example, states require periodic financial reports and enforce minimum capital or restricted cash reserve requirements. Health plans and insurance companies are also regulated under state insurance holding company regulations and some of our activities may be subject to other health care-related regulations and requirements, including regulations and licensure requirements related to Preferred Provider Organizations, MCOs, UR and TPAs. Under state guaranty association laws, certain insurance companies can be assessed (up to prescribed limits) for certain obligations to the policyholders and claimants of impaired or insolvent insurance companies that write the same line or similar lines of business. Any such assessment could expose our insurance entities and other insurers to the risk they would be required to pay a portion of an impaired or insolvent insurance company’s claims through state guaranty associations.
Some of our businesses provide products or services to government agencies. For example, some of our Optum and UnitedHealthcare businesses hold government contracts or provide services related to government contracts and are subject to U.S. federal and state and non-U.S. self-referral, anti-kickback, medical necessity, risk adjustment, false claims and other laws and regulations governing government contractors and the use of government funds. Our relationships with these government agencies are subject to the terms of our contracts with the agencies and to laws and regulations regarding government contracts. Certain laws and regulations restrict or prohibit companies from performing work for government agencies that might be viewed to involve an actual or potential conflict of interest. These laws and regulations may limit our ability to pursue and perform certain types of engagements, thereby materially and adversely affecting our results of operations, financial position and cash flows.
Some of our Optum businesses are also subject to regulations distinct from those faced by our insurance and HMO subsidiaries, some of which could impact our relationships with physicians, hospitals and customers. These regulations include state telemedicine regulations; debt collection laws; banking regulations; consumer financial protection laws; distributor and producer licensing requirements; state corporate practice of medicine restrictions; fee-splitting rules; and health care facility licensure and certificate of need requirements. These risks and uncertainties may materially and adversely affect our ability to market or provide our products and services, or to achieve targeted operating margins, or may increase the regulatory burdens under which we operate.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 18/25]
The laws and regulations governing our businesses and interpretations of those laws and regulations are subject to frequent and often unpredictable change. For example, legislative, administrative and public policy changes to the ACA have been and likely will continue to be considered, and we cannot predict if the ACA will be further modified or to what extent such modifications may impact our businesses or member enrollment. Additionally, changes in tax laws or unfavorable resolutions of exams could create additional tax liabilities.
The integration of entities we acquire into our businesses may affect the way in which existing laws and regulations apply to us, including by subjecting us to laws and regulations which did not previously apply to us. The broad latitude given to the agencies administering, interpreting and enforcing current and future regulations governing our businesses could compel us to change how we do business, renegotiate existing contracts and other arrangements, restrict revenue and enrollment growth, increase our health care and administrative costs and capital requirements, or expose us to increased liability in courts for coverage determinations, resolution of commercial disputes and other actions.
We also must obtain and maintain regulatory approvals to market many of our products and services, increase prices for some regulated products and services and complete or integrate strategic transactions. For example, premium rates for our health insurance and managed care products are subject to regulatory review or approval in many states and by the federal government. Additionally, we must submit data on proposed rate increases to HHS on many of our products for monitoring purposes. Geographic and product expansions of our businesses may be subject to state and federal regulatory approvals. Delays in obtaining necessary approvals or our failure to obtain or maintain adequate approvals could materially and adversely affect our results of operations, financial position and cash flows.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 19/25]
We also currently operate outside of the United States and in the future may acquire or commence additional businesses based outside of the United States, increasing our exposure to non-U.S. regulatory regimes. Our failure to comply with U.S. or non-U.S. laws and regulations governing our conduct outside the United States or to establish constructive relationships with non-U.S. regulators could adversely affect our ability to market our products and services or to do so at targeted operating margins, which may have a material adverse effect on our business, financial condition and results of operations. Non-U.S. regulatory regimes, which vary by jurisdiction, encompass, among other matters, local and cross-border taxation, licensing, tariffs, intellectual property, investment, capital (including minimum solvency margin and reserve requirements), management control, labor, anti-fraud, anti-corruption and privacy and data protection regulations (including requirements for cross-border data transfers). Any foreign regulator or court may take an approach to the interpretation, implementation and enforcement of industry regulations which could differ from the approach taken by U.S. regulators or courts. In addition, our non-U.S. businesses and operations are subject to U.S. laws regulating the conduct and activities of U.S.-based businesses operating outside the United States, such as the FCPA, which prohibits offering, promising, providing or authorizing others to give anything of value to a foreign government official to obtain or retain business or otherwise secure a business advantage.
The health care industry is regularly subject to negative publicity, including as a result of governmental investigations, adverse media coverage and political debate concerning industry regulation. Negative publicity may adversely affect our stock price, damage our reputation, and expose us to unexpected or unwarranted regulatory scrutiny.
As a result of our participation in various government health care programs, both as a payer and as a service provider to payers, we are exposed to additional risks associated with program funding, enrollments, payment adjustments, audits and government investigations which could materially and adversely affect our business, results of operations, financial position and cash flows.
We participate in various federal, state and local government health care benefit programs, including as a payer in Medicare Advantage, Medicare Part D, various Medicaid programs and CHIP, and receive substantial revenues from these programs. Some of our Optum businesses also provide services to payers participating in government health care programs. A reduction or less than expected increase, or a protracted delay, in government funding for these programs or change in allocation methodologies, or termination of the contract at the option of the government, has affected and in future periods may materially and adversely affect our results of operations, financial position and cash flows.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 20/25]
The government health care programs in which we participate are generally subject to frequent changes, including changes which may reduce the number of persons enrolled or eligible for coverage (such as Medicaid eligibility redeterminations in certain states and federal enhanced premium subsidy reductions), reduce the amount of reimbursement or payment levels, reduce our participation in, or prevent our expansion into, certain service areas or markets, or increase our administrative or medical costs under such programs. Revenues for these programs depend on periodic funding from the federal government or applicable state governments and allocation of the funding through various payment mechanisms. Funding for these government programs depends on many factors outside of our control, including general economic conditions and budgetary constraints at the federal or applicable state level. For example, CMS in the past has reduced or frozen Medicare Advantage benchmarks, and additional cuts to Medicare Advantage benchmarks are possible. In addition, from time to time, CMS makes changes to the way it calculates Medicare Advantage risk adjustment payments. Although we have adjusted members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and
operating cost management in response to the benchmark reductions and other funding pressures, these or other strategies may not fully address the funding pressures in the Medicare Advantage program. In addition, payers in the Medicare Advantage program may be subject to reductions in payments from CMS as a result of decreased funding or recoupment pursuant to government audit. States have also made changes in rates and reimbursements for Medicaid members and audits can result in unexpected recoupments.
---
SEC Filing: sec.gov/…↗
MetricDuck Viewer: viewer.metricduck.com/…#section-risk_factors↗
Accession: 0000731766-26-000062
Citation: mdck://UNH/0000731766-26-000062/risk_factors#c10
Chunk handles (cite the chunk a quoted figure came from):
c10 → mdck://UNH/0000731766-26-000062/risk_factors#c10
c11 → mdck://UNH/0000731766-26-000062/risk_factors#c11
c12 → mdck://UNH/0000731766-26-000062/risk_factors#c12
c13 → mdck://UNH/0000731766-26-000062/risk_factors#c13
c14 → mdck://UNH/0000731766-26-000062/risk_factors#c14
c15 → mdck://UNH/0000731766-26-000062/risk_factors#c15
c16 → mdck://UNH/0000731766-26-000062/risk_factors#c16
c17 → mdck://UNH/0000731766-26-000062/risk_factors#c17
c18 → mdck://UNH/0000731766-26-000062/risk_factors#c18
c19 → mdck://UNH/0000731766-26-000062/risk_factors#c19
›get_filing_section(cik="0000731766", section_id="risk_factors", offset=20)—Page 3 of 3
**Structured tables in this filing** — disaggregated figures behind this section's prose. Query these (not the prose) for the numbers:
- `table_debt_maturities` — Debt Maturities Schedule
- `table_deferred_taxes` — Deferred Tax Assets and Liabilities
- `table_fair_value` — Fair Value Measurements Schedule
- `table_goodwill` — Goodwill Schedule
- `table_ppe` — Property, Plant and Equipment Schedule
- `table_segment_reporting` — Segment Reporting Schedule
Or read the as-filed percentages directly: `get_xbrl_facts(cik="0000731766", search="concentration")` (revenue share by customer / channel / geography / product).
**Other sections in this filing:**
- `accountant_changes` (Changes in and Disagreements with Accountants) — ~14 words
- `business_description` (Business Description) — ~6,691 words
- `controls_procedures` (Controls and Procedures) — ~1,191 words
- `cybersecurity` (Cybersecurity) — ~805 words
- `footnote_accounting_policies` (Summary of Significant Accounting Policies) — ~5,387 words
- `footnote_business_combinations` (Business Combinations) — ~579 words
- `footnote_cash_investments` (Cash and Investments) — ~3,106 words
- `footnote_commitments` (Commitments and Contingencies) — ~1,114 words
- `footnote_credit_loss` (Allowance for Credit Losses) — ~104 words
- `footnote_debt` (Debt and Credit Facilities) — ~2,437 words
- `footnote_derivatives` (Derivative Financial Instruments) — ~525 words
- `footnote_eps` (Earnings Per Share) — ~345 words
- `footnote_equity` (Stockholders' Equity) — ~1,078 words
- `footnote_fair_value` (Fair Value Measurements) — ~2,855 words
- `footnote_goodwill` (Goodwill and Intangible Assets) — ~1,585 words
- `footnote_income_tax` (Income Taxes) — ~3,632 words
- `footnote_leases` (Leases) — ~111 words
- `footnote_pension` (Pension and Post-Retirement Benefits) — ~126 words
- `footnote_ppe` (Property, Plant and Equipment) — ~4,021 words
- `footnote_revenue` (Revenue Recognition) — ~1,134 words
- `footnote_segment` (Segment Information) — ~4,799 words
- `footnote_stock_comp` (Stock-Based Compensation) — ~2,012 words
- `footnotes_introduction` (Notes to Financial Statements - Introduction) — ~83 words
- `legal_proceedings` (Legal Proceedings) — ~54 words
- `market_equity` (Market for Common Equity) — ~273 words
- `market_risk` (Market Risk Disclosures) — ~587 words
- `mda_critical_accounting` (Critical Accounting Policies)
- `mda_full` (Management's Discussion and Analysis) — ~26,327 words
- `mda_liquidity` (Liquidity and Capital Resources)
- `mda_outlook`
- `mda_results_operations` (Results of Operations)
- `mine_safety` (Mine Safety Disclosures) — ~10 words
- `other_information_10k` (Other Information (10-K)) — ~66 words
- `policy_cash_equivalents` (Cash and Cash Equivalents Policy) — ~45 words
- `policy_consolidation` (Consolidation Policy) — ~43 words
- `policy_fair_value` (Fair Value Measurement Policy) — ~1,003 words
- `policy_leases` (Leases Policy) — ~111 words
- `policy_ppe` (Property, Plant and Equipment Policy) — ~130 words
- `policy_receivables` (Receivables and Credit Loss Policy) — ~172 words
- `policy_revenue_recognition` (Revenue Recognition Policy) — ~1,134 words
- `properties` (Properties) — ~453 words
- `risk_factors_risks_related_to_our_business_and_our_industry`
- `risk_factors_risks_related_to_the_regulation_of_our_business`
- `signature_officers` (Signatures (Executive Officers)) — ~489 words
- `table_debt_maturities` (Debt Maturities Schedule) — ~64 words
- `table_deferred_taxes` (Deferred Tax Assets and Liabilities) — ~343 words
- `table_fair_value` (Fair Value Measurements Schedule) — ~678 words
- `table_goodwill` (Goodwill Schedule) — ~237 words
- `table_ppe` (Property, Plant and Equipment Schedule) — ~42 words
- `table_segment_reporting` (Segment Reporting Schedule) — ~2,300 words
- `unresolved_staff_comments` (Unresolved Staff Comments) — ~6 words
_Drill in via `get_filing_section(cik="0000731766", accession_number="0000731766-26-000062", section_id="...")`._
25Thinking
I have good coverage now. I can see a key difference already emerging: in the FY2025 10-K (chunk 11), there is a standalone risk heading "Our increasing use of AI presents legal, regulatory and business risks to our operations, reputation and financial results." which appears to be a NEW, dedicated risk heading inserted between "legal actions" and "strategic alliances" that was NOT present in the FY2024 10-K. In FY2024, chunk 11 goes directly from the legal actions risk to the "strategic alliances" risk with no AI-specific standalone risk header.
Let me now get the final pages (offset=20) for both filings to see the remaining risk factors.
26Narration
I've spotted a key new risk heading in FY2025. Let me pull the final pages of both to complete the comparison.
27Tool call·get_filing_section
{
"ticker": "UNH",
"section_id": "risk_factors",
"accession_number": "0000731766-26-000062",
"offset": 20,
"max_chars": 30000
}
28Tool call·get_filing_section
{
"ticker": "UNH",
"section_id": "risk_factors",
"accession_number": "0000731766-25-000063",
"offset": 20,
"max_chars": 30000
}
29Result·get_filing_section✓ ok · 18,861 ch
# UNH — risk_factors
10-K FY FY2025 (filed 2026-03-02)
~11,725 words | Chunks 21-25 of 25
[UNH | 10-K FY 2025 | Risk Factors | Chunk 21/25]
Under the Medicaid managed care program, state Medicaid agencies solicit bids from eligible health plans to continue their participation in the acute care Medicaid health programs. If we are not successful in obtaining renewals of state Medicaid managed care contracts, we risk losing the members who were enrolled in those Medicaid programs. Under the Medicare Part D program, to qualify for automatic enrollment of low income members, our bids must result in an enrollee premium below a regional benchmark, which is calculated by the government after all regional bids are submitted. If the enrollee premium is not below the government benchmark, we risk losing the members who were auto-assigned to us and will not have additional members auto-assigned to us. Chronic failure to meet the benchmarks could result in termination of these government contracts. In general, our bids are based upon certain assumptions regarding enrollment, utilization, medical costs and other factors. If any of these assumptions are materially incorrect, either as a result of unforeseen changes to the programs on which we bid, implementation of material program or policy changes after our bid submission, or submissions by our competitors at lower rates than our bids, our results of operations, financial position and cash flows could be materially and adversely affected.
Many of the government health care coverage programs we participate in are subject to the prior satisfaction of certain conditions or performance standards or benchmarks. For example, as part of the ACA, CMS has a system providing various quality bonus payments to Medicare Advantage plans meeting specified quality star ratings at the individual plan or local contract level. The star rating system considers various measures adopted by CMS, including, among others, quality of care, preventive services, chronic illness management, handling of appeals and customer satisfaction. Plans must have a rating of four stars or higher to qualify for bonus payments, and CMS has made and may make additional changes to the star rating program that impact the ability of our plans to achieve four-star or higher ratings. If we do not maintain or continue to improve our star ratings, our plans may not be eligible for quality bonuses and we may experience a negative impact on our revenues and the benefits our plans can offer, which could materially and adversely affect the marketability of our plans and the number of people we serve. Any changes in standards or care delivery models applying to government health care programs, including Medicare and Medicaid, or our inability to maintain or improve our quality scores and star ratings to meet evolving government performance requirements or to match the performance of our competitors could result in limitations to our participation in or exclusion from these or other government programs, which could materially and adversely affect our results of operations, financial position and cash flows.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 22/25]
CMS uses various payment mechanisms to allocate funding and adjust monthly capitation payments for Medicare programs. For Medicare Advantage plans, these adjustments are made according to the predicted health status of each beneficiary as supported by data from health care providers. For Medicare Part D plans, payment adjustments are driven by risk-sharing provisions based on a comparison of costs forecasted in our annual bids to actual prescription drug costs. Some state Medicaid programs utilize a similar process. For example, our UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State businesses submit information relating to the health status of enrollees to CMS or state agencies for purposes of determining the amount of certain payments to us. CMS and the Office of Inspector General for HHS periodically perform risk adjustment data validation (RADV) audits of selected Medicare health plans to validate the coding practices of and supporting documentation maintained by health care providers. Some of our local plans have been selected for such audits, which in the past have resulted and in future periods could result in retrospective adjustments to payments made to our health plans, fines, corrective action plans or other adverse action by CMS.
We have been and in the future may become involved in routine, regular and special governmental investigations, audits, reviews and assessments. Such investigations, audits, reviews or assessments sometimes arise out of, or prompt claims or class action lawsuits by private litigants or whistleblowers regarding, among other allegations, claims that we failed to disclose certain business practices or, as a government contractor, submitted false or erroneous claims to the government. Government investigations, audits, reviews and assessments could lead to government actions, which have resulted and in future periods could result in adverse publicity, the assessment of damages, civil or criminal fines or penalties, or other sanctions, including restrictions or changes in the way we conduct business, loss of licensure or exclusion from participation in government programs, any of which could have a material adverse effect on our business, results of operations, financial position and cash flows.
Our pharmacy care services businesses face regulatory and operational risks and uncertainties which may differ from the risks of our other businesses.
We provide pharmacy care services through our Optum Rx and UnitedHealthcare businesses. Each business is subject to federal and state anti-kickback, beneficiary inducement and other laws governing the relationships of the business with pharmaceutical manufacturers, physicians, pharmacies, customers and consumers. In addition, federal and state legislatures regularly consider new regulations for the industry which could materially affect current industry practices, including potential new legislation and
[UNH | 10-K FY 2025 | Risk Factors | Chunk 23/25]
regulations regarding the receipt or disclosure of rebates and other fees from pharmaceutical companies, the development and use of formularies and other utilization management tools, the use of average wholesale prices or other pricing benchmarks, pricing for specialty pharmaceuticals, limited access to networks, and pharmacy network reimbursement methodologies.
Further, various governmental agencies have conducted and continue to conduct investigations and studies into certain PBM practices, which have resulted and in future periods may result in PBMs agreeing to civil penalties, including the payment of money and entry into corporate integrity agreements, or could materially and adversely impact the PBM business model. As a provider of pharmacy benefit management services, Optum Rx is also subject to an increasing number of licensure, registration and other laws and accreditation standards. Optum Rx conducts business through home delivery, specialty and compounding pharmacies, pharmacies located in community mental health centers and home infusion, which subjects it to extensive federal, state and local laws and regulations, including those of the DEA and individual state controlled substance authorities, the Food and Drug Administration and Boards of Pharmacy.
We could face potential claims in connection with purported errors by our home delivery, specialty or compounding or clinic-based pharmacies or the provision of home infusion services, as well as claims related to the inherent risks in the packaging and distribution of pharmaceuticals and other health care products. Disruptions from any of our home delivery, specialty pharmacy or home infusion services could materially and adversely affect our results of operations, financial position and cash flows.
In addition, our pharmacy care services businesses provide services to sponsors of health benefit plans subject to ERISA. A private party or the DOL, which is the agency that enforces ERISA, could assert that fiduciary obligations imposed by the statute apply to some or all of the services provided by our pharmacy care services businesses even where those businesses are not contractually obligated to assume fiduciary obligations. If a court were to determine such fiduciary obligations apply, we could be subject to claims for breaches of fiduciary obligations or claims we entered into prohibited transactions.
If we fail to comply with applicable privacy, security, technology and data laws, regulations and standards, including with respect to third-party service providers utilizing protected personal information on our behalf, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 24/25]
The collection, maintenance, protection, use, transmission, disclosure and disposal of protected personal information are regulated at the federal, state, international and industry levels and addressed in requirements of our customer contracts. Additionally, legislative and regulatory action in the United States at the federal, state and local levels, as well as internationally, is emerging in the areas of AI and automation. These laws, regulations and requirements are subject to frequent and often unpredictable change. Compliance with new privacy, security, technology and data laws, regulations and requirements may result in increased operating costs, and may constrain or require us to alter our business model or operations.
Internationally, many of the jurisdictions in which we operate have established their own data security and privacy legal framework with which we or our customers must comply. We expect there will continue to be new proposed laws, regulations and industry standards concerning privacy, data protection, information security, and AI/ML and automation in the European Union, UK, Chile, India and other jurisdictions, which may have negative impacts on our businesses or the businesses of our customers.
HIPAA requires business associates as well as covered entities to comply with specified privacy and security requirements. While we provide for appropriate protections through our contracts with our third-party service providers and in certain cases assess their security controls, we have limited oversight or control over their actions and practices. Several of our businesses act as business associates to their covered entity customers and, as a result, collect, use, disclose and maintain protected personal information in order to provide services to these customers. If HHS alleges or finds noncompliance by us with HIPAA privacy or security requirements, the allegations or findings could damage our reputation and subject us to monetary and other sanctions.
Through our Optum businesses, we maintain a database of administrative and clinical data statistically de-identified in accordance with HIPAA standards. Noncompliance or findings of noncompliance with applicable laws, regulations or requirements, or the occurrence of any privacy or security breach involving the misappropriation, loss or other unauthorized disclosure of protected personal information, whether by us or by one of our third-party service providers, could have an adverse effect on our reputation and business and, among other consequences, could subject us to mandatory disclosure to affected customers and the media, loss of existing or new customers, and significant increases in the cost of managing and remediating privacy or security incidents, and could also result in significant fines, penalties and litigation awards. Any of these consequences could have a material and adverse effect on our results of operations, financial position and cash flows.
[UNH | 10-K FY 2025 | Risk Factors | Chunk 25/25]
We increasingly rely on new and evolving technologies, including those powered by or incorporating AI, as part of our internal operations and in the delivery of our products and services. AI technologies are subject to evolving and uncertain U.S. federal, state, and international laws and regulations. Emerging requirements may impose new compliance obligations, increase operating costs, or limit certain uses of AI.
Restrictions on our ability to obtain funds from our regulated subsidiaries could materially and adversely affect our ability to reinvest in our business, service our debt and return capital to our shareholders.
Because we operate as a holding company, we are dependent on dividends and administrative expense reimbursements from our subsidiaries to fund our obligations. Many of these subsidiaries are regulated by state departments of insurance or similar regulatory authorities. We are also required by law or regulation to maintain specific prescribed minimum amounts of capital in these subsidiaries. The levels of required capitalization depend primarily on the volume of premium revenues generated and medical costs incurred by the applicable subsidiary. In most states, we are required to seek approval by state regulatory authorities before we transfer money or pay dividends from our regulated subsidiaries exceeding specified amounts. An inability of our regulated subsidiaries to pay dividends to their parent companies in the desired amounts or at the time of our choosing could adversely affect our ability to reinvest in our business through capital expenditures or business acquisitions, as well as our ability to maintain our corporate quarterly dividend payment, repurchase shares of our common stock and repay our debt. If we are unable to obtain sufficient funds from our subsidiaries to fund our obligations, our results of operations, financial position and cash flows could be materially and adversely affected.
---
SEC Filing: sec.gov/…↗
MetricDuck Viewer: viewer.metricduck.com/…#section-risk_factors↗
Accession: 0000731766-26-000062
Citation: mdck://UNH/0000731766-26-000062/risk_factors#c20
Chunk handles (cite the chunk a quoted figure came from):
c20 → mdck://UNH/0000731766-26-000062/risk_factors#c20
c21 → mdck://UNH/0000731766-26-000062/risk_factors#c21
c22 → mdck://UNH/0000731766-26-000062/risk_factors#c22
c23 → mdck://UNH/0000731766-26-000062/risk_factors#c23
c24 → mdck://UNH/0000731766-26-000062/risk_factors#c24
End of section.
**Structured tables in this filing** — disaggregated figures behind this section's prose. Query these (not the prose) for the numbers:
- `table_debt_maturities` — Debt Maturities Schedule
- `table_deferred_taxes` — Deferred Tax Assets and Liabilities
- `table_fair_value` — Fair Value Measurements Schedule
- `table_goodwill` — Goodwill Schedule
- `table_ppe` — Property, Plant and Equipment Schedule
- `table_segment_reporting` — Segment Reporting Schedule
Or read the as-filed percentages directly: `get_xbrl_facts(cik="0000731766", search="concentration")` (revenue share by customer / channel / geography / product).
**Other sections in this filing:**
- `accountant_changes` (Changes in and Disagreements with Accountants) — ~14 words
- `business_description` (Business Description) — ~6,691 words
- `controls_procedures` (Controls and Procedures) — ~1,191 words
- `cybersecurity` (Cybersecurity) — ~805 words
- `footnote_accounting_policies` (Summary of Significant Accounting Policies) — ~5,387 words
- `footnote_business_combinations` (Business Combinations) — ~579 words
- `footnote_cash_investments` (Cash and Investments) — ~3,106 words
- `footnote_commitments` (Commitments and Contingencies) — ~1,114 words
- `footnote_credit_loss` (Allowance for Credit Losses) — ~104 words
- `footnote_debt` (Debt and Credit Facilities) — ~2,437 words
- `footnote_derivatives` (Derivative Financial Instruments) — ~525 words
- `footnote_eps` (Earnings Per Share) — ~345 words
- `footnote_equity` (Stockholders' Equity) — ~1,078 words
- `footnote_fair_value` (Fair Value Measurements) — ~2,855 words
- `footnote_goodwill` (Goodwill and Intangible Assets) — ~1,585 words
- `footnote_income_tax` (Income Taxes) — ~3,632 words
- `footnote_leases` (Leases) — ~111 words
- `footnote_pension` (Pension and Post-Retirement Benefits) — ~126 words
- `footnote_ppe` (Property, Plant and Equipment) — ~4,021 words
- `footnote_revenue` (Revenue Recognition) — ~1,134 words
- `footnote_segment` (Segment Information) — ~4,799 words
- `footnote_stock_comp` (Stock-Based Compensation) — ~2,012 words
- `footnotes_introduction` (Notes to Financial Statements - Introduction) — ~83 words
- `legal_proceedings` (Legal Proceedings) — ~54 words
- `market_equity` (Market for Common Equity) — ~273 words
- `market_risk` (Market Risk Disclosures) — ~587 words
- `mda_critical_accounting` (Critical Accounting Policies)
- `mda_full` (Management's Discussion and Analysis) — ~26,327 words
- `mda_liquidity` (Liquidity and Capital Resources)
- `mda_outlook`
- `mda_results_operations` (Results of Operations)
- `mine_safety` (Mine Safety Disclosures) — ~10 words
- `other_information_10k` (Other Information (10-K)) — ~66 words
- `policy_cash_equivalents` (Cash and Cash Equivalents Policy) — ~45 words
- `policy_consolidation` (Consolidation Policy) — ~43 words
- `policy_fair_value` (Fair Value Measurement Policy) — ~1,003 words
- `policy_leases` (Leases Policy) — ~111 words
- `policy_ppe` (Property, Plant and Equipment Policy) — ~130 words
- `policy_receivables` (Receivables and Credit Loss Policy) — ~172 words
- `policy_revenue_recognition` (Revenue Recognition Policy) — ~1,134 words
- `properties` (Properties) — ~453 words
- `risk_factors_risks_related_to_our_business_and_our_industry`
- `risk_factors_risks_related_to_the_regulation_of_our_business`
- `signature_officers` (Signatures (Executive Officers)) — ~489 words
- `table_debt_maturities` (Debt Maturities Schedule) — ~64 words
- `table_deferred_taxes` (Deferred Tax Assets and Liabilities) — ~343 words
- `table_fair_value` (Fair Value Measurements Schedule) — ~678 words
- `table_goodwill` (Goodwill Schedule) — ~237 words
- `table_ppe` (Property, Plant and Equipment Schedule) — ~42 words
- `table_segment_reporting` (Segment Reporting Schedule) — ~2,300 words
- `unresolved_staff_comments` (Unresolved Staff Comments) — ~6 words
_Drill in via `get_filing_section(cik="0000731766", accession_number="0000731766-26-000062", section_id="...")`._
30Result·get_filing_section✓ ok · 19,476 ch
# UNH — risk_factors
10-K FY FY2024 (filed 2025-02-27)
~12,116 words | Chunks 21-26 of 26
[UNH | 10-K FY 2024 | Risk Factors | Chunk 21/26]
Under the Medicaid managed care program, state Medicaid agencies solicit bids from eligible health plans to continue their participation in the acute care Medicaid health programs. If we are not successful in obtaining renewals of state Medicaid managed care contracts, we risk losing the members who were enrolled in those Medicaid programs. Under the Medicare Part D program, to qualify for automatic enrollment of low income members, our bids must result in an enrollee premium below a regional benchmark, which is calculated by the government after all regional bids are submitted. If the enrollee premium is not below the government benchmark, we risk losing the members who were auto-assigned to us and will not have additional members auto-assigned to us. Chronic failure to meet the benchmarks could result in termination of these government contracts. In general, our bids are based upon certain assumptions regarding enrollment, utilization, medical costs and other factors. If any of these assumptions are materially incorrect, either as a result of unforeseen changes to the programs on which we bid, implementation of material program or policy changes after our bid submission, or submissions by our competitors at lower rates than our bids, our results of operations, financial position and cash flows could be materially and adversely affected.
Many of the government health care coverage programs we participate in are subject to the prior satisfaction of certain conditions or performance standards or benchmarks. For example, as part of the ACA, CMS has a system providing various quality bonus payments to Medicare Advantage plans meeting specified quality star ratings at the individual plan or local contract level. The star rating system considers various measures adopted by CMS, including, among others, quality of care, preventive services, chronic illness management, handling of appeals and customer satisfaction. Plans must have a rating of four stars or higher to qualify for bonus payments, and CMS has and may make changes to the star rating program that impact the ability of plans to achieve four-star or higher ratings. If we do not maintain or continue to improve our star ratings, our plans may not be eligible for quality bonuses and we may experience a negative impact on our revenues and the benefits our plans can offer, which could materially and adversely affect the marketability of our plans and the number of people we serve. Any changes in standards or care delivery models applying to government health care programs, including Medicare and Medicaid, or our inability to maintain or improve our quality scores and star ratings to meet evolving government performance requirements or to match the performance of our competitors could result in limitations to our participation in or exclusion from these or other government programs, which could materially and adversely affect our results of operations, financial position and cash flows.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 22/26]
CMS uses various payment mechanisms to allocate funding and adjust monthly capitation payments for Medicare programs. For Medicare Advantage plans, these adjustments are made according to the predicted health status of each beneficiary as supported by data from health care providers. For Medicare Part D plans, payment adjustments are driven by risk-sharing provisions based on a comparison of costs forecasted in our annual bids to actual prescription drug costs. Some state Medicaid programs utilize a similar process. For example, our UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State businesses submit information relating to the health status of enrollees to CMS or state agencies for
purposes of determining the amount of certain payments to us. CMS and the Office of Inspector General for HHS periodically perform risk adjustment data validation (RADV) audits of selected Medicare health plans to validate the coding practices of and supporting documentation maintained by health care providers. Some of our local plans have been selected for such audits, which in the past have resulted and in future periods could result in retrospective adjustments to payments made to our health plans, fines, corrective action plans or other adverse action by CMS.
We have been and in the future may become involved in routine, regular and special governmental investigations, audits, reviews and assessments. Such investigations, audits, reviews or assessments sometimes arise out of, or prompt claims by private litigants or whistleblowers regarding, among other allegations, claims that we failed to disclose certain business practices or, as a government contractor, submitted false or erroneous claims to the government. Government investigations, audits, reviews and assessments could lead to government actions, which have resulted and in future periods could result in adverse publicity, the assessment of damages, civil or criminal fines or penalties, or other sanctions, including restrictions or changes in the way we conduct business, loss of licensure or exclusion from participation in government programs, any of which could have a material adverse effect on our business, results of operations, financial position and cash flows.
Our pharmacy care services businesses face regulatory and operational risks and uncertainties which may differ from the risks of our other businesses.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 23/26]
We provide pharmacy care services through our Optum Rx and UnitedHealthcare businesses. Each business is subject to federal and state anti-kickback, beneficiary inducement and other laws governing the relationships of the business with pharmaceutical manufacturers, physicians, pharmacies, customers and consumers. In addition, federal and state legislatures regularly consider new regulations for the industry which could materially affect current industry practices, including potential new legislation and regulations regarding the receipt or disclosure of rebates and other fees from pharmaceutical companies, the development and use of formularies and other utilization management tools, the use of average wholesale prices or other pricing benchmarks, pricing for specialty pharmaceuticals, limited access to networks and pharmacy network reimbursement methodologies. Further, various governmental agencies have conducted and continue to conduct investigations and studies into certain PBM practices, which have resulted and in future periods may result in PBMs agreeing to civil penalties, including the payment of money and entry into corporate integrity agreements, or could materially and adversely impact the PBM business model. As a provider of pharmacy benefit management services, Optum Rx is also subject to an increasing number of licensure, registration and other laws and accreditation standards. Optum Rx conducts business through home delivery, specialty and compounding pharmacies, pharmacies located in community mental health centers and home infusion, which subjects it to extensive federal, state and local laws and regulations, including those of the DEA and individual state controlled substance authorities, the Food and Drug Administration and Boards of Pharmacy.
We could face potential claims in connection with purported errors by our home delivery, specialty or compounding or clinic-based pharmacies or the provision of home infusion services, as well as claims related to the inherent risks in the packaging and distribution of pharmaceuticals and other health care products. Disruptions from any of our home delivery, specialty pharmacy or home infusion services could materially and adversely affect our results of operations, financial position and cash flows.
In addition, our pharmacy care services businesses provide services to sponsors of health benefit plans subject to ERISA. A private party or the DOL, which is the agency that enforces ERISA, could assert that fiduciary obligations imposed by the statute apply to some or all of the services provided by our pharmacy care services businesses even where those businesses are not contractually obligated to assume fiduciary obligations. If a court were to determine such fiduciary obligations apply, we could be subject to claims for breaches of fiduciary obligations or claims we entered into prohibited transactions.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 24/26]
If we fail to comply with applicable privacy, security, technology and data laws, regulations and standards, including with respect to third-party service providers utilizing protected personal information on our behalf, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.
The collection, maintenance, protection, use, transmission, disclosure and disposal of protected personal information are regulated at the federal, state, international and industry levels and addressed in requirements of our customer contracts. Additionally, legislative and regulatory action in the United States at the federal, state and local levels, as well as internationally, is emerging in the areas of AI/ML and automation. These laws, regulations and requirements are subject to change. Compliance with new privacy, security, technology and data laws, regulations and requirements may result in increased operating costs, and may constrain or require us to alter our business model or operations.
Internationally, many of the jurisdictions in which we operate have established their own data security and privacy legal framework with which we or our customers must comply. We expect there will continue to be new proposed laws, regulations and industry standards concerning privacy, data protection, information security, and AI/ML and automation in the European Union, UK, Chile, India and other jurisdictions, and we cannot yet determine the impacts such future laws, regulations and standards may have on our businesses or the businesses of our customers.
Some of our businesses are also subject to the Payment Card Industry Data Security Standard, which is a multifaceted security standard designed to protect payment card account data.
HIPAA requires business associates as well as covered entities to comply with specified privacy and security requirements. While we provide for appropriate protections through our contracts with our third-party service providers and in certain cases assess their security controls, we have limited oversight or control over their actions and practices. Several of our businesses act as business associates to their covered entity customers and, as a result, collect, use, disclose and maintain protected personal information in order to provide services to these customers. If HHS alleges or finds noncompliance with HIPAA privacy or security requirements, the allegations or findings could damage our reputation and subject us to monetary and other sanctions.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 25/26]
Through our Optum businesses, we maintain a database of administrative and clinical data statistically de-identified in accordance with HIPAA standards. Noncompliance or findings of noncompliance with applicable laws, regulations or requirements, or the occurrence of any privacy or security breach involving the misappropriation, loss or other unauthorized disclosure of protected personal information, whether by us or by one of our third-party service providers, could have an adverse effect on our reputation and business and, among other consequences, could subject us to mandatory disclosure to affected customers and the media, loss of existing or new customers, significant increases in the cost of managing and remediating privacy or security incidents, and could also result in significant fines, penalties and litigation awards. Any of these consequences could have a material and adverse effect on our results of operations, financial position and cash flows.
As an enterprise, we increasingly rely on new and evolving technologies, including those powered by or incorporating AI/ML, as part of our internal operations and in the delivery of our products and services. New technologies have potential and power to improve and optimize operational processes and clinical outcomes across the healthcare system, but also present ethical, technological, legal, regulatory and other risks. With respect to AI/ML, we have developed and implemented policies and procedures intended to promote and sustain responsible design, development, and use of AI/ML, consistent with industry best practices. Any inadequacy or failure in compliance with our responsible use of AI/ML policies and procedures or emerging laws, regulations and standards governing AI/ML use could cause our technology products not to operate as intended or to produce outcomes, including possible regulatory enforcement action or litigation that could have a material and adverse effect on our business, reputation, results of operations, financial position and cash flows.
Restrictions on our ability to obtain funds from our regulated subsidiaries could materially and adversely affect our ability to reinvest in our business, service our debt and return capital to our shareholders.
[UNH | 10-K FY 2024 | Risk Factors | Chunk 26/26]
Because we operate as a holding company, we are dependent on dividends and administrative expense reimbursements from our subsidiaries to fund our obligations. Many of these subsidiaries are regulated by state departments of insurance or similar regulatory authorities. We are also required by law or regulation to maintain specific prescribed minimum amounts of capital in these subsidiaries. The levels of capitalization required depend primarily on the volume of premium revenues generated by the applicable subsidiary. In most states, we are required to seek approval by state regulatory authorities before we transfer money or pay dividends from our regulated subsidiaries exceeding specified amounts. An inability of our regulated subsidiaries to pay dividends to their parent companies in the desired amounts or at the time of our choosing could adversely affect our ability to reinvest in our business through capital expenditures or business acquisitions, as well as our ability to maintain our corporate quarterly dividend payment, repurchase shares of our common stock and repay our debt. If we are unable to obtain sufficient funds from our subsidiaries to fund our obligations, our results of operations, financial position and cash flows could be materially and adversely affected.
---
SEC Filing: sec.gov/…↗
Accession: 0000731766-25-000063
Citation: mdck://UNH/0000731766-25-000063/risk_factors#c20
Chunk handles (cite the chunk a quoted figure came from):
c20 → mdck://UNH/0000731766-25-000063/risk_factors#c20
c21 → mdck://UNH/0000731766-25-000063/risk_factors#c21
c22 → mdck://UNH/0000731766-25-000063/risk_factors#c22
c23 → mdck://UNH/0000731766-25-000063/risk_factors#c23
c24 → mdck://UNH/0000731766-25-000063/risk_factors#c24
c25 → mdck://UNH/0000731766-25-000063/risk_factors#c25
End of section.
**Structured tables in this filing** — disaggregated figures behind this section's prose. Query these (not the prose) for the numbers:
- `table_debt_maturities` — Debt Maturities Schedule
- `table_deferred_taxes` — Deferred Tax Assets and Liabilities
- `table_fair_value` — Fair Value Measurements Schedule
- `table_goodwill` — Goodwill Schedule
- `table_ppe` — Property, Plant and Equipment Schedule
- `table_segment_reporting` — Segment Reporting Schedule
Or read the as-filed percentages directly: `get_xbrl_facts(cik="0000731766", search="concentration")` (revenue share by customer / channel / geography / product).
**Other sections in this filing:**
- `accountant_changes` (Changes in and Disagreements with Accountants) — ~14 words
- `business_description` (Business Description) — ~6,686 words
- `controls_procedures` (Controls and Procedures) — ~1,191 words
- `cybersecurity` (Cybersecurity) — ~790 words
- `footnote_accounting_policies` (Summary of Significant Accounting Policies) — ~3,700 words
- `footnote_cash_investments` (Cash and Investments) — ~894 words
- `footnote_commitments` (Commitments and Contingencies) — ~1,009 words
- `footnote_debt` (Debt and Credit Facilities) — ~1,852 words
- `footnote_derivatives` (Derivative Financial Instruments) — ~419 words
- `footnote_eps` (Earnings Per Share) — ~350 words
- `footnote_equity` (Stockholders' Equity) — ~976 words
- `footnote_fair_value` (Fair Value Measurements) — ~2,572 words
- `footnote_goodwill` (Goodwill and Intangible Assets) — ~1,387 words
- `footnote_income_tax` (Income Taxes) — ~2,762 words
- `footnote_leases` (Leases) — ~111 words
- `footnote_pension` (Pension and Post-Retirement Benefits) — ~65 words
- `footnote_ppe` (Property, Plant and Equipment) — ~4,091 words
- `footnote_revenue` (Revenue Recognition) — ~1,078 words
- `footnote_segment` (Segment Information) — ~3,117 words
- `footnote_stock_comp` (Stock-Based Compensation) — ~1,825 words
- `footnotes_introduction` (Notes to Financial Statements - Introduction) — ~83 words
- `legal_proceedings` (Legal Proceedings) — ~54 words
- `market_equity` (Market for Common Equity) — ~239 words
- `market_risk` (Market Risk Disclosures) — ~431 words
- `mda_critical_accounting` (Critical Accounting Policies)
- `mda_full` (Management's Discussion and Analysis) — ~22,613 words
- `mda_liquidity` (Liquidity and Capital Resources)
- `mda_outlook`
- `mda_results_operations` (Results of Operations)
- `mine_safety` (Mine Safety Disclosures) — ~6 words
- `other_information_10k` (Other Information (10-K)) — ~66 words
- `policy_cash_equivalents` (Cash and Cash Equivalents Policy) — ~42 words
- `policy_consolidation` (Consolidation Policy) — ~30 words
- `policy_fair_value` (Fair Value Measurement Policy) — ~917 words
- `policy_leases` (Leases Policy) — ~111 words
- `policy_ppe` (Property, Plant and Equipment Policy) — ~130 words
- `policy_receivables` (Receivables and Credit Loss Policy) — ~172 words
- `policy_revenue_recognition` (Revenue Recognition Policy) — ~1,078 words
- `properties` (Properties) — ~442 words
- `risk_factors_risks_related_to_our_business_and_our_industry`
- `risk_factors_risks_related_to_the_regulation_of_our_business`
- `signature_officers` (Signatures (Executive Officers)) — ~489 words
- `table_debt_maturities` (Debt Maturities Schedule) — ~64 words
- `table_deferred_taxes` (Deferred Tax Assets and Liabilities) — ~359 words
- `table_fair_value` (Fair Value Measurements Schedule) — ~658 words
- `table_goodwill` (Goodwill Schedule) — ~236 words
- `table_ppe` (Property, Plant and Equipment Schedule) — ~42 words
- `table_segment_reporting` (Segment Reporting Schedule) — ~1,994 words
- `unresolved_staff_comments` (Unresolved Staff Comments) — ~10 words
_Drill in via `get_filing_section(cik="0000731766", accession_number="0000731766-25-000063", section_id="...")`._
31Thinking
Now I have the complete risk factors from both the FY2025 and FY2024 10-K filings. Let me do a thorough comparison.
**FY2025 10-K** (filed 2026-03-02, accession 0000731766-26-000062) - 25 chunks
**FY2024 10-K** (filed 2025-02-27, accession 0000731766-25-000063) - 26 chunks
Let me now compile the key risk headings from both filings and identify what's new or changed.
**Risk Headings in FY2025 (25 chunks):**
Looking at the risk factors under "Risks Related to Our Business and Our Industry," I can see the major categories include medical cost estimation and pricing, data integrity and information systems, cybersecurity and data privacy incidents, relationships with healthcare providers and payers, and competitive positioning in the market.
The list continues with exposure to legal actions and investigations, a new risk category around AI use and its regulatory implications, challenges with strategic alliances and acquisitions, public health crises and natural disasters, the need to maintain a network of independent producers and consultants, economic conditions, and talent attraction and development.
Now I'm looking at financial and operational risks—potential losses in investment portfolios, impairment of intangible assets, intellectual property protection, credit rating downgrades, and the highly regulated nature of healthcare operations across multiple jurisdictions. The thinking also touches on ongoing regulatory scrutiny in the healthcare industry. 2. Data integrity and availability issues could undermine our operations... (chunk 2-4)
3. Cyberattacks or data security breaches by us or our partners pose significant risks... (chunk 4-6)
4. Maintaining strong relationships with payers, providers, and healthcare networks is critical to our success... (chunk 6-8)
5. We need to stay competitive to preserve and grow our market position... (chunk 8-9)
6. We face ongoing legal actions and government investigations as part of our business... (chunk 9-11)
7. Successfully executing strategic partnerships and acquisitions is essential for our growth strategy... (chunk 11-12)
8. Public health emergencies and large-scale medical crises create operational uncertainties... (chunk 12-13)
9. Our ability to attract and retain talent directly impacts sales performance...
10. Economic downturns create headwinds for our business operations... (chunk 13-14)
11. Losing key talent or failing to develop succession plans threatens our leadership continuity... (chunk 14)
12. Our investment holdings are exposed to potential losses... (chunk 14-15)
13. Significant impairment of intangible assets would hurt our financial position... (chunk 15)
14. Protecting our intellectual property is crucial to maintaining competitive advantage... (chunk 15-16)
15. Credit rating downgrades would increase our financing costs... (chunk 16)
16. Our heavily regulated operations across multiple jurisdictions create compliance complexity... (chunk 16-18)
17. Negative industry publicity can damage our reputation and business prospects... (chunk 19)
18. Participation in government healthcare programs exposes us to additional regulatory and financial risks... (chunk 19-22)
19. Our pharmacy services face distinct regulatory and operational challenges... (chunk 22-23)
20. Failing to comply with privacy, security, and data protection laws creates legal exposure... (chunk 23-25)
21. Restrictions on accessing funds from regulated subsidiaries could constrain our financial flexibility... (chunk 25-26)
Now I'm noticing a significant structural change in FY2025 — there's a brand new standalone risk factor dedicated entirely to AI, which wasn't broken out separately in FY2024. Previously, AI and machine learning risks were scattered throughout other risk factors like data systems and privacy compliance, but now UNH is giving it its own dedicated heading. I'm also seeing that the investment portfolio risk has been expanded to explicitly include loans, reflecting their Optum Financial business segment. Goodwill increased slightly in absolute terms to $131 billion but decreased as a percentage of total assets from 44% to 42%. I also notice that FY2025 removed a specific reference to PCI DSS compliance that appeared in FY2024's privacy section, and the government program changes discussion became more detailed with mentions of federal enhancements.
The government investigations language expanded to explicitly include class action lawsuits and whistleblower claims, and there's now a dedicated paragraph on AI regulatory compliance that emphasizes the company's increasing reliance on AI technologies in operations and service delivery.
I'm also noticing the structural differences between the two years—FY2024 had 26 chunks while FY2025 has 25, but FY2025 introduces a brand new standalone heading specifically focused on AI risks to operations, reputation, and financial results, whereas FY2024 had embedded AI/ML mentions scattered across the IT systems section and privacy/data laws sections.
32Final emit
DigestPayload ·12,281 chars
I now have the complete picture across all 25 FY2025 chunks and 26 FY2024 chunks. Here is the full analysis.
---
## UNH Risk Factor Analysis — FY2025 vs. FY2024 10-K
**Sources:**
- FY2025 10-K: filed **2026-03-02**, accession `0000731766-26-000062`
- FY2024 10-K: filed **2025-02-27**, accession `0000731766-25-000063`
---
### Part 1 — Key Disclosed Risks (present in BOTH filings)
UNH organizes its risk factors into two buckets: **Risks Related to Our Business and Our Industry** and **Risks Related to the Regulation of Our Business**. All of the following major headings appear in both the FY2025 and FY2024 10-Ks:
#### Risks Related to the Business and Industry
| # | Risk Heading | Both Years? |
|---|---|---|
| 1 | **Medical cost estimation & pricing** — premium revenues from risk-based products are ~80% of total revenues; small underestimates in medical cost trend materially affect results; specific factors now include medical inflation, utilization, provider billing intensity, climate change, pandemics, drug cost spikes | ✅ |
| 2 | **Data/IT system integrity** — reliance on timely, accurate health data across electronic health records, AI-powered platforms, clinical decision systems; failure to consolidate or upgrade systems causes operational and reputational harm | ✅ |
| 3 | **Cybersecurity / data breach** — ongoing exposure after the Change Healthcare cyberattack (2024); risk of ransomware, malware, insider threats; third-party vendor vulnerabilities outside UNH's direct control | ✅ |
| 4 | **Provider relationship risk** — failure to contract with physicians, hospitals, ACOs, or physician management groups at competitive rates; risk-based arrangements with providers expose UNH if those providers become insolvent | ✅ |
| 5 | **Competitive position** — market share loss if UNH fails to innovate in value-based care, virtual/in-home care, AI-driven analytics; disruptive new entrants; competitor consolidation | ✅ |
| 6 | **Litigation & legal actions** — routinely subject to tort, antitrust, False Claims Act, whistleblower, class-action, and malpractice suits; largely self-insured | ✅ |
| 7 | **Strategic alliances & M&A integration** — failure to integrate acquired businesses (including IT systems); antitrust enforcement (FTC/DOJ) risk on strategic transactions | ✅ |
| 8 | **Public health crises / pandemics / natural disasters** — wildfires, hurricanes, climate events could increase medical costs; government emergency powers could disrupt pharmacy supply chains | ✅ |
| 9 | **Independent producer/distributor network** — sales depend on non-exclusive brokers and consultants; commission and relationship risk | ✅ |
| 10 | **Unfavorable macroeconomic conditions** — employer coverage cancellations; reduced Medicare/Medicaid reimbursements in budget-constrained environments; impact on Optum customers | ✅ |
| 11 | **Key employee / succession risk** — high demand for health care and technology executives; hybrid/remote work expands the pool of competing employers | ✅ |
| 12 | **Investment (and loan) portfolio losses** — interest rate volatility; default risk on corporate and municipal bonds | ✅ |
| 13 | **Goodwill / intangible asset impairment** — $131B carrying value of goodwill and intangibles (42% of total assets at Dec 31, 2025); divestiture-related impairment charges | ✅ |
| 14 | **Intellectual property protection** — databases, software, and proprietary data; third-party infringement in health-care software | ✅ |
| 15 | **Credit rating downgrades** — affect cost and availability of debt capital | ✅ |
#### Risks Related to the Regulation of the Business
| # | Risk Heading | Both Years? |
|---|---|---|
| 16 | **U.S. and international regulatory environment** — ACA changes; tax law changes; state insurance solvency/capital minimums; licensing; FCPA compliance internationally | ✅ |
| 17 | **Negative publicity / political scrutiny** — governmental investigations, adverse media, political debate around health insurance industry regulation | ✅ |
| 18 | **Government program funding** — Medicare Advantage benchmark cuts by CMS; Medicaid redeterminations; CHIP funding; RADV audits and risk adjustment repayments | ✅ |
| 19 | **Pharmacy/PBM regulation** — Optum Rx subject to anti-kickback laws, DEA, FDA, state boards of pharmacy, rebate transparency requirements; PBM investigation risk | ✅ |
| 20 | **Privacy, data security & technology law** — HIPAA, state privacy laws, international data protection (EU, UK, India), AI/ML regulation | ✅ |
| 21 | **Holding company dividend / capital restrictions** — regulated subsidiaries must maintain minimum capital; state approval required before dividends exceed specified amounts | ✅ |
---
### Part 2 — NEW Risk Factors Added in FY2025 vs. FY2024
There is **one new, standalone risk heading** in the FY2025 10-K that does not appear as a separate heading in the FY2024 10-K:
---
#### 🆕 NEW (FY2025 only): "Our increasing use of AI presents legal, regulatory and business risks to our operations, reputation and financial results."
*(FY2025 10-K, chunk 11 — inserted between the Litigation risk and the M&A/Strategic Alliances risk)*
**What it says (verbatim excerpt):**
> *"We increasingly rely on technologies powered by or incorporating AI in our internal operations and in the delivery of products and services. While these technologies present opportunities to improve efficiency, enhance customer experience, and optimize clinical and administrative processes, they also entail risks and uncertainties… to the extent an AI system does not operate as intended or produces an inaccurate, incomplete or biased output, the system could impact operations, customer service or other functions and could have an adverse effect on our business, reputation, results of operations, financial position and cash flows."*
**Why this is notable:** In FY2024, AI risk was embedded as supporting language *within* two other risk factors (the IT/data systems section and the privacy/data law section) under the label "AI/ML." In FY2025, UNH elevated AI risk to its **own named risk heading**, signaling that AI governance, regulatory exposure, and output-quality risk have matured into a top-level enterprise concern in their own right. The FY2025 filing also consistently drops the "ML" suffix to refer to the technology simply as "AI" — reflecting the industry shift to discussing generative AI rather than traditional machine learning.
---
### Part 3 — Notable Augmentations / Sharpening of Existing Risks (YoY)
Beyond the new heading, several existing risks were materially expanded or sharpened in FY2025 vs. FY2024:
| Existing Risk | FY2024 Language | FY2025 Change |
|---|---|---|
| **Medical cost risk** | Listed factors: "medical cost inflation, increased use of services, business mix, unexpected differences among new customer populations…" | Added **"increased provider billing intensity"** as an explicit new cost driver |
| **Government program risk** | Examples of coverage reductions: "Medicaid eligibility redeterminations in certain states" | Added **"federal enhanced premium subsidy reductions"** as a second explicit example, reflecting ACA subsidy cliff risk |
| **Government investigations** | "claims by private litigants or whistleblowers" | Expanded to **"claims or class action lawsuits by private litigants or whistleblowers"** — raising the salience of class action exposure |
| **Investment risk heading** | "Our investment portfolio may sustain losses…" | Renamed to **"Our investment and loan portfolio may sustain losses…"** — explicitly adding loan portfolio risk, consistent with Optum Financial Services growth |
| **Credit rating risk** | Standard language | Added new sentence: "We have been the subject of downgrades and other negative credit rating actions in past periods" — explicitly acknowledging that downgrades have already occurred, which was not in FY2024 |
| **Goodwill impairment** | $130B, 44% of total assets (Dec 31, 2024) | **$131B, 42% of total assets** (Dec 31, 2025) — larger absolute value but lower concentration ratio |
---
### Summary
All 21 substantive risk categories in UNH's FY2024 10-K carry over verbatim or with refinements into the FY2025 10-K. The single most material structural change is the elevation of **AI governance and regulatory risk into its own standalone risk heading** — something that was embedded language in FY2024 but is now a first-class named risk in FY2025. Secondary enhancements reflect lived experience: explicit acknowledgment of prior credit rating downgrades, addition of "increased provider billing intensity" as a cost driver (relevant to the FY2024 medical cost margin pressure), and broadened government program risk language to include federal ACA subsidy reductions.
---
FINAL ANSWER:
**Filing identifiers used:**
- FY2025 10-K: filed 2026-03-02, accession 0000731766-26-000062
- FY2024 10-K: filed 2025-02-27, accession 0000731766-25-000063
**Key disclosed risks present in BOTH filings (present in FY2024 and FY2025):**
1. Medical cost estimation & pricing risk (~80% of revenues are risk-based premiums; cost underestimation materially impairs results)
2. Data / IT system integrity (reliance on AI-powered health data platforms; system consolidation failures)
3. Cybersecurity / data breach (ongoing post-Change Healthcare 2024 cyberattack; ransomware, insider threats, third-party vendor exposure)
4. Provider relationship risk (network adequacy, ACO/physician group bargaining power, insolvency of risk-bearing providers)
5. Competitive position (value-based care innovation, disruptive entrants, competitor consolidation)
6. Litigation & legal actions (tort, antitrust, False Claims Act, class-action, malpractice; largely self-insured)
7. Strategic alliances & M&A integration (IT vulnerabilities in acquired businesses; FTC/DOJ antitrust scrutiny)
8. Public health crises / pandemics / natural disasters (climate events, pandemic-related cost spikes, government emergency powers)
9. Independent producer / distributor network
10. Unfavorable macroeconomic conditions (employer benefit cancellations, Medicaid/Medicare reimbursement pressure)
11. Key employee / executive succession
12. Investment (and loan) portfolio losses
13. Goodwill / intangible asset impairment ($130B→$131B carrying value)
14. Intellectual property protection
15. Credit rating downgrades
16. U.S. and international regulatory environment (ACA, tax law, state capital requirements)
17. Negative publicity / political scrutiny of health insurance industry
18. Government program funding (Medicare Advantage benchmark cuts, Medicaid redeterminations, RADV audits)
19. Pharmacy / PBM regulation (Optum Rx; anti-kickback, DEA, rebate transparency)
20. Privacy, data security & technology law (HIPAA, state laws, international data protection, AI regulation)
21. Holding company dividend / capital flow restrictions from regulated subsidiaries
**New risk factor added in FY2025 (not a standalone heading in FY2024):**
- "Our increasing use of AI presents legal, regulatory and business risks to our operations, reputation and financial results." — This is a brand-new dedicated risk heading in the FY2025 10-K (chunk 11 of risk_factors section). In FY2024, AI/ML risk was only embedded as supporting language within the IT/data systems and privacy/data law sections; in FY2025 it was elevated to a first-class named risk, covering the risk that AI systems produce inaccurate, incomplete, or biased outputs, and that evolving AI regulations could impose new compliance obligations or limit certain uses of AI.
**Notable augmentations to existing risks YoY (not new headings, but material sharpening):**
- Medical cost risk: FY2025 added "increased provider billing intensity" as an explicit new cost driver
- Government program risk: FY2025 added "federal enhanced premium subsidy reductions" as an explicit ACA subsidy cliff example
- Credit rating risk: FY2025 explicitly acknowledged "we have been the subject of downgrades and other negative credit rating actions in past periods" (not in FY2024)
- Investment risk: FY2025 heading expanded from "investment portfolio" to "investment and loan portfolio," adding explicit loan exposure (consistent with Optum Financial growth)
A real, unedited AI agent + MetricDuck run (Sonnet 4.6, MetricDuck MCP only), captured from MetricDuck's own evaluation set — gold read from primary SEC EDGAR (never MetricDuck's own output); verdict = pass. Curation is limited to the short summary; the trace itself — thinking, tool calls, results, and final answer — is exactly as captured. See the method →
MetricDuck — the free, self-serve first-source financial data layer beneath whatever agent you run (not another model). Every figure is traced back to its source — click any to verify.
Run this on your own ticker — connect your agent in 30 seconds.